{
  "DOI": "10.1007/s00439-021-02385-x",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-021-02385-x",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eBoth safety and efficacy of medical treatment can vary depending on the ethnogeographic background of the patient. One of the reasons underlying this variability is differences in pharmacogenetic polymorphisms in genes involved in drug disposition, as well as in drug targets. Knowledge and appreciation of these differences is thus essential to optimize population-stratified care. Here, we provide an extensive updated analysis of population pharmacogenomics in ten pharmacokinetic genes (\u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003e, \u003cjats:italic\u003eCYP2C19\u003c/jats:italic\u003e, \u003cjats:italic\u003eDPYD\u003c/jats:italic\u003e, \u003cjats:italic\u003eTPMT\u003c/jats:italic\u003e, \u003cjats:italic\u003eNUDT15\u003c/jats:italic\u003e and \u003cjats:italic\u003eSLC22A1\u003c/jats:italic\u003e), drug targets (\u003cjats:italic\u003eCFTR\u003c/jats:italic\u003e) and genes involved in drug hypersensitivity (\u003cjats:italic\u003eHLA-A\u003c/jats:italic\u003e, \u003cjats:italic\u003eHLA-B\u003c/jats:italic\u003e) or drug-induced acute hemolytic anemia (\u003cjats:italic\u003eG6PD\u003c/jats:italic\u003e). Combined, polymorphisms in the analyzed genes affect the pharmacology, efficacy or safety of 141 different drugs and therapeutic regimens. The data reveal pronounced differences in the genetic landscape, complexity and variant frequencies between ethnogeographic groups. Reduced function alleles of \u003cjats:italic\u003eCYP2D6\u003c/jats:italic\u003e, \u003cjats:italic\u003eSLC22A1\u003c/jats:italic\u003e and \u003cjats:italic\u003eCFTR\u003c/jats:italic\u003e were most prevalent in individuals of European descent, whereas \u003cjats:italic\u003eDPYD\u003c/jats:italic\u003e and \u003cjats:italic\u003eTPMT\u003c/jats:italic\u003e deficiencies were most common in Sub-Saharan Africa. Oceanian populations showed the highest frequencies of \u003cjats:italic\u003eCYP2C19\u003c/jats:italic\u003e loss-of-function alleles while their inferred CYP2D6 activity was among the highest worldwide. Frequencies of \u003cjats:italic\u003eHLA-B*15:02\u003c/jats:italic\u003e and \u003cjats:italic\u003eHLA-B*58:01\u003c/jats:italic\u003e were highest across Asia, which has important implications for the risk of severe cutaneous adverse reactions upon treatment with carbamazepine and allopurinol. \u003cjats:italic\u003eG6PD\u003c/jats:italic\u003e deficiencies were most frequent in Africa, the Middle East and Southeast Asia with pronounced differences in variant composition. These variability data provide an important resource to inform cost-effectiveness modeling and guide population-specific genotyping strategies with the goal of optimizing the implementation of precision public health.\u003c/jats:p\u003e",
  "alternative-id": [
    "2385"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "10 August 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "5 October 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "15 October 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "YZ and VML are co-founders and shareholders of PersoMedix AB. In addition, VML is CEO and shareholder of HepaPredict AB and discloses consultancy work for Enginzyme AB."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Yitian",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-1140-6204",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Lauschke",
      "given": "Volker M.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        10,
        15
      ]
    ],
    "date-time": "2021-10-15T09:45:09Z",
    "timestamp": 1634291109000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        6,
        9
      ]
    ],
    "date-time": "2022-06-09T02:08:30Z",
    "timestamp": 1654740510000
  },
  "funder": [
    {
      "DOI": "10.13039/501100004359",
      "award": [
        "2016-01153",
        "2016-01154",
        "2019-01837"
      ],
      "doi-asserted-by": "publisher",
      "name": "Vetenskapsrådet"
    },
    {
      "DOI": "10.13039/501100010767",
      "award": [
        "875510"
      ],
      "doi-asserted-by": "publisher",
      "name": "Innovative Medicines Initiative"
    },
    {
      "DOI": "10.13039/100010661",
      "award": [
        "668353"
      ],
      "doi-asserted-by": "publisher",
      "name": "Horizon 2020 Framework Programme"
    },
    {
      "DOI": "10.13039/501100004047",
      "doi-asserted-by": "crossref",
      "name": "Karolinska Institute"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        3,
        27
      ]
    ],
    "date-time": "2024-03-27T23:08:44Z",
    "timestamp": 1711580924813
  },
  "is-referenced-by-count": 16,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "6",
  "issued": {
    "date-parts": [
      [
        2021,
        10,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "6",
    "published-print": {
      "date-parts": [
        [
          2022,
          6
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            15
          ]
        ],
        "date-time": "2021-10-15T00:00:00Z",
        "timestamp": 1634256000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            10,
            15
          ]
        ],
        "date-time": "2021-10-15T00:00:00Z",
        "timestamp": 1634256000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02385-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s00439-021-02385-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02385-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1113-1136",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        10,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        10,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        6
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.poamed.2016.06.007",
      "author": "A Adehin",
      "doi-asserted-by": "publisher",
      "first-page": "144",
      "journal-title": "Pol Ann Med",
      "key": "2385_CR1",
      "unstructured": "Adehin A, Bolaji OO, Kennedy MA, Adeagbo BA (2017) Allele frequencies of thiopurine S-methyltransferase (TPMT) variants in the Nigerian population. Pol Ann Med 24:144–147. https://doi.org/10.1016/j.poamed.2016.06.007",
      "volume": "24",
      "year": "2017"
    },
    {
      "DOI": "10.1097/00008571-199708000-00010",
      "author": "JA Agúndez",
      "doi-asserted-by": "publisher",
      "first-page": "337",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR2",
      "unstructured": "Agúndez JA, Ramirez R, Hernandez M, Llerena A, Benítez J (1997) Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: impact of gene-flow from Europe. Pharmacogenetics 7:337–340. https://doi.org/10.1097/00008571-199708000-00010",
      "volume": "7",
      "year": "1997"
    },
    {
      "author": "E Aklillu",
      "first-page": "441",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "2385_CR3",
      "unstructured": "Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, Ingelman-Sundberg M (1996) Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther 278:441–446",
      "volume": "278",
      "year": "1996"
    },
    {
      "DOI": "10.1097/00008571-200207000-00005",
      "author": "E Aklillu",
      "doi-asserted-by": "publisher",
      "first-page": "375",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR4",
      "unstructured": "Aklillu E, Herrlin K, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M (2002) Evidence for environmental influence on CYP2D6-catalysed debrisoquine hydroxylation as demonstrated by phenotyping and genotyping of Ethiopians living in Ethiopia or in Sweden. Pharmacogenetics 12:375–383. https://doi.org/10.1097/00008571-200207000-00005",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1186/1471-2326-10-6",
      "author": "N Al-Allawi",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "BMC Blood Disord",
      "key": "2385_CR5",
      "unstructured": "Al-Allawi N, Eissa AA, Jubrael JM, Jamal SA, Hamamy H (2010) Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq. BMC Blood Disord 10:6. https://doi.org/10.1186/1471-2326-10-6",
      "volume": "10",
      "year": "2010"
    },
    {
      "DOI": "10.2217/pme.13.56",
      "author": "J Albuquerque",
      "doi-asserted-by": "publisher",
      "first-page": "709",
      "journal-title": "Per Med",
      "key": "2385_CR6",
      "unstructured": "Albuquerque J, Ribeiro C, Naranjo MEG, Llerena A, Grazina M (2013) Characterization of CYP2D6 genotypes and metabolic profiles in the Portuguese population: pharmacogenetic implications. Per Med 10:709–718. https://doi.org/10.2217/pme.13.56",
      "volume": "10",
      "year": "2013"
    },
    {
      "DOI": "10.5858/2005-129-1144-mcogdg",
      "author": "S Alfadhli",
      "doi-asserted-by": "publisher",
      "first-page": "1144",
      "journal-title": "Arch Pathol Lab Med",
      "key": "2385_CR7",
      "unstructured": "Alfadhli S, Kaaba S, Elshafey A, Salim M, AlAwadi A, Bastaki L (2005) Molecular characterization of glucose-6-phosphate dehydrogenase gene defect in the Kuwaiti population. Arch Pathol Lab Med 129:1144–1147. https://doi.org/10.5858/2005-129-1144-mcogdg",
      "volume": "129",
      "year": "2005"
    },
    {
      "DOI": "10.1093/hmg/8.2.367",
      "author": "MM Ameyaw",
      "doi-asserted-by": "publisher",
      "first-page": "367",
      "journal-title": "Hum Mol Genet",
      "key": "2385_CR8",
      "unstructured": "Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8:367–370. https://doi.org/10.1093/hmg/8.2.367",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.2217/pgs.09.28",
      "author": "U Amstutz",
      "doi-asserted-by": "publisher",
      "first-page": "931",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR9",
      "unstructured": "Amstutz U, Farese S, Aebi S, Largiadèr CR (2009) Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment. Pharmacogenomics 10:931–944. https://doi.org/10.2217/pgs.09.28",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1097/FTD.0b013e318260b46e",
      "author": "MV Antunes",
      "doi-asserted-by": "publisher",
      "first-page": "422",
      "journal-title": "Ther Drug Monit",
      "key": "2385_CR10",
      "unstructured": "Antunes MV, Linden R, Santos TV, Wallemacq P, Haufroid V, Classen JF, Andreolla H, Costa N, Fontanive TO, Rosa DD (2012) Endoxifen levels and its association with CYP2D6 genotype and phenotype: evaluation of a southern Brazilian population under tamoxifen pharmacotherapy. Ther Drug Monit 34:422–431. https://doi.org/10.1097/FTD.0b013e318260b46e",
      "volume": "34",
      "year": "2012"
    },
    {
      "DOI": "10.1038/tpj.2015.78",
      "author": "C Arimany-Nardi",
      "doi-asserted-by": "publisher",
      "first-page": "473",
      "journal-title": "Pharmacogenomics J",
      "key": "2385_CR11",
      "unstructured": "Arimany-Nardi C, Koepsell H, Pastor-Anglada M (2015) Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions. Pharmacogenomics J 15:473–487. https://doi.org/10.1038/tpj.2015.78",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1002/14651858.CD012040.pub2",
      "author": "AA Aslam",
      "doi-asserted-by": "publisher",
      "first-page": "CD012040",
      "journal-title": "Cochrane Database Syst Rev",
      "key": "2385_CR12",
      "unstructured": "Aslam AA, Higgins C, Sinha IP, Southern KW (2017) Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. Cochrane Database Syst Rev 1:CD012040. https://doi.org/10.1002/14651858.CD012040.pub2",
      "volume": "1",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s12936-018-2538-4",
      "author": "A Assefa",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "Malar J",
      "key": "2385_CR13",
      "unstructured": "Assefa A, Ali A, Deressa W, Tsegaye W, Abebe G, Sime H, Kebede A, Jima D, Kassa M, Abreha T, Teka H, Solomon H, Malone J, Shi YP, Zhou Z, Reithinger R, Hwang J (2018) Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study. Malar J 17:388. https://doi.org/10.1186/s12936-018-2538-4",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1038/nature15393",
      "author": "A Auton",
      "doi-asserted-by": "publisher",
      "first-page": "68",
      "journal-title": "Nature",
      "key": "2385_CR14",
      "unstructured": "Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526:68–74. https://doi.org/10.1038/nature15393",
      "volume": "526",
      "year": "2015"
    },
    {
      "DOI": "10.1186/s12936-018-2271-z",
      "author": "SS Awandu",
      "doi-asserted-by": "publisher",
      "first-page": "120",
      "journal-title": "Malar J",
      "key": "2385_CR15",
      "unstructured": "Awandu SS, Raman J, Makhanthisa TI, Kruger P, Frean J, Bousema T, Niemand J, Birkholtz LM (2018) Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa. Malar J 17:120. https://doi.org/10.1186/s12936-018-2271-z",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cbf.1222",
      "author": "M Aydin",
      "doi-asserted-by": "publisher",
      "first-page": "133",
      "journal-title": "Cell Biochem Funct",
      "key": "2385_CR16",
      "unstructured": "Aydin M, Hatirnaz O, Erensoy N, Ozbek U (2005) CYP2D6 and CYP1A1 mutations in the Turkish population. Cell Biochem Funct 23:133–135. https://doi.org/10.1002/cbf.1222",
      "volume": "23",
      "year": "2005"
    },
    {
      "DOI": "10.1053/cp.1999.v66.100072001",
      "author": "AS Aynacioglu",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR17",
      "unstructured": "Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schröder T, Kayaalp SO, Roots I, Brockmöller J (1999) Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin Pharmacol Ther 66:185–192. https://doi.org/10.1053/cp.1999.v66.100072001",
      "volume": "66",
      "year": "1999"
    },
    {
      "DOI": "10.1080/15257771003720418",
      "author": "A Bahari",
      "doi-asserted-by": "publisher",
      "first-page": "237",
      "journal-title": "Nucleosides Nucleotides Nucleic Acids",
      "key": "2385_CR18",
      "unstructured": "Bahari A, Hashemi M, Bari Z, Moazeni-Roodi A, Kaykhaei MA, Narouie B (2010) Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population. Nucleosides Nucleotides Nucleic Acids 29:237–244. https://doi.org/10.1080/15257771003720418",
      "volume": "29",
      "year": "2010"
    },
    {
      "DOI": "10.1177/135965350801300508",
      "author": "WP Bannister",
      "doi-asserted-by": "publisher",
      "first-page": "687",
      "journal-title": "Antivir Ther",
      "key": "2385_CR19",
      "unstructured": "Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD (2008) Incidence of abacavir hypersensitivity reactions in euroSIDA. Antivir Ther 13:687–696",
      "volume": "13",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s00216-010-4597-4",
      "author": "B Beer",
      "doi-asserted-by": "publisher",
      "first-page": "2361",
      "journal-title": "Anal Bioanal Chem",
      "key": "2385_CR20",
      "unstructured": "Beer B, Erb R, Pitterl F, Niederstätter H, Maroñas O, Gesteira A, Carracedo A, Piatkov I, Oberacher H (2011) CYP2D6 genotyping by liquid chromatography-electrospray ionization mass spectrometry. Anal Bioanal Chem 400:2361–2370. https://doi.org/10.1007/s00216-010-4597-4",
      "volume": "400",
      "year": "2011"
    },
    {
      "DOI": "10.1006/bcmd.2002.0490",
      "author": "E Beutler",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Blood Cells Mol Dis",
      "key": "2385_CR21",
      "unstructured": "Beutler E, Vulliamy TJ (2002) Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 28:93–103. https://doi.org/10.1006/bcmd.2002.0490",
      "volume": "28",
      "year": "2002"
    },
    {
      "DOI": "10.1016/0006-2952(93)90045-x",
      "author": "JP Bökkerink",
      "doi-asserted-by": "publisher",
      "first-page": "1455",
      "journal-title": "Biochem Pharmacol",
      "key": "2385_CR22",
      "unstructured": "Bökkerink JP, Stet EH, De Abreu RA, Damen FJ, Hulscher TW, Bakker MA, van Baal JA (1993) 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T lymphoblasts. Biochem Pharmacol 45:1455–1463. https://doi.org/10.1016/0006-2952(93)90045-x",
      "volume": "45",
      "year": "1993"
    },
    {
      "DOI": "10.1080/03014460.2017.1378368",
      "author": "F Carano",
      "doi-asserted-by": "publisher",
      "first-page": "66",
      "journal-title": "Ann Hum Biol",
      "key": "2385_CR23",
      "unstructured": "Carano F, Sarno S, De Fanti S, Serventi P, Bini C, Luiselli D, Pelotti S (2018) Genetic variability of CYP2D6, CYP2B6, CYP2C9 and CYP2C19 genes across the Italian Peninsula. Ann Hum Biol 45:66–71. https://doi.org/10.1080/03014460.2017.1378368",
      "volume": "45",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2013.172",
      "author": "KE Caudle",
      "doi-asserted-by": "publisher",
      "first-page": "640",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR24",
      "unstructured": "Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, Schwab M (2013) Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing. Clin Pharmacol Ther 94:640–645. https://doi.org/10.1038/clpt.2013.172",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.15517/rbt.v62i4.12916",
      "author": "C Céspedes-Garro",
      "doi-asserted-by": "publisher",
      "first-page": "1659",
      "journal-title": "Rev Biol Trop",
      "key": "2385_CR25",
      "unstructured": "Céspedes-Garro C, Jiménez-Arce G, Naranjo ME, Barrantes R, Llerena A (2014) Ethnic background and CYP2D6 genetic polymorphisms in Costa Ricans. Rev Biol Trop 62:1659–1671",
      "volume": "62",
      "year": "2014"
    },
    {
      "DOI": "10.1111/j.1365-2141.2006.06463.x",
      "author": "R Chalvam",
      "doi-asserted-by": "publisher",
      "first-page": "512",
      "journal-title": "Br J Haematol",
      "key": "2385_CR26",
      "unstructured": "Chalvam R, Mukherjee MB, Colah RB, Mohanty D, Ghosh K (2007) G6PD Namoru (208 T–\u003e C) is the major polymorphic variant in the tribal populations in southern India. Br J Haematol 136:512–513. https://doi.org/10.1111/j.1365-2141.2006.06463.x",
      "volume": "136",
      "year": "2007"
    },
    {
      "DOI": "10.1097/00008571-200204000-00003",
      "author": "JG Chang",
      "doi-asserted-by": "publisher",
      "first-page": "191",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR27",
      "unstructured": "Chang JG, Lee LS, Chen CM, Shih MC, Wu MC, Tsai FJ, Liang DC (2002) Molecular analysis of thiopurine S-methyltransferase alleles in South-east Asian populations. Pharmacogenetics 12:191–195. https://doi.org/10.1097/00008571-200204000-00003",
      "volume": "12",
      "year": "2002"
    },
    {
      "DOI": "10.1097/mib.0000000000001148",
      "author": "K Chao",
      "doi-asserted-by": "publisher",
      "first-page": "1592",
      "journal-title": "Inflamm Bowel Dis",
      "key": "2385_CR28",
      "unstructured": "Chao K, Wang X, Cao Q, Qian J, Wu K, Zhu X, Yang H, Liang J, Lin L, Huang Z, Zhang Y, Huang Y, Sun Y, Xue X, Huang M, Hu P, Lan P, Gao X (2017) Combined detection of NUDT15 variants could highly predict thiopurine-induced leukopenia in chinese patients with inflammatory bowel disease: a multicenter analysis. Inflamm Bowel Dis 23:1592–1599. https://doi.org/10.1097/mib.0000000000001148",
      "volume": "23",
      "year": "2017"
    },
    {
      "DOI": "10.1124/jpet.110.170159",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "journal-title": "J Pharmacol Exp Ther",
      "key": "2385_CR29",
      "unstructured": "Chen L, Takizawa M, Chen E, Schlessinger A, Segenthelar J, Choi JH, Sali A, Kubo M, Nakamura S, Iwamoto Y, Iwasaki N, Giacomini KM (2010) Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function. J Pharmacol Exp Ther 335:42–50. https://doi.org/10.1124/jpet.110.170159",
      "volume": "335",
      "year": "2010"
    },
    {
      "DOI": "10.1073/pnas.1314939111",
      "author": "L Chen",
      "doi-asserted-by": "publisher",
      "first-page": "9983",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "2385_CR30",
      "unstructured": "Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ, Chien HC, Zhang Y, Morrissey KM, Liu J, Ostrem J, Younger NS, Kurhanewicz J, Shokat KM, Ashrafi K, Giacomini KM (2014) OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A 111:9983–9988. https://doi.org/10.1073/pnas.1314939111",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1038/jhg.2011.77",
      "author": "HS Cheong",
      "doi-asserted-by": "publisher",
      "first-page": "666",
      "journal-title": "J Hum Genet",
      "key": "2385_CR31",
      "unstructured": "Cheong HS, Kim HD, Na HS, Kim JO, Kim LH, Kim SH, Bae JS, Chung MW, Shin HD (2011) Screening of genetic variations of SLC15A2, SLC22A1, SLC22A2 and SLC22A6 genes. J Hum Genet 56:666–670. https://doi.org/10.1038/jhg.2011.77",
      "volume": "56",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s12936-018-2248-y",
      "author": "CS Chu",
      "doi-asserted-by": "publisher",
      "first-page": "101",
      "journal-title": "Malar J",
      "key": "2385_CR32",
      "unstructured": "Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L (2018) Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. Malar J 17:101. https://doi.org/10.1186/s12936-018-2248-y",
      "volume": "17",
      "year": "2018"
    },
    {
      "DOI": "10.1038/428486a",
      "author": "WH Chung",
      "doi-asserted-by": "publisher",
      "first-page": "486",
      "journal-title": "Nature",
      "key": "2385_CR33",
      "unstructured": "Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004) Medical genetics: a marker for Stevens–Johnson syndrome. Nature 428:486. https://doi.org/10.1038/428486a",
      "volume": "428",
      "year": "2004"
    },
    {
      "DOI": "10.1002/cbf.1561",
      "author": "C Correia",
      "doi-asserted-by": "publisher",
      "first-page": "251",
      "journal-title": "Cell Biochem Funct",
      "key": "2385_CR34",
      "unstructured": "Correia C, Santos P, Coutinho AM, Vicente AM (2009) Characterization of pharmacogenetically relevant CYP2D6 and ABCB1 gene polymorphisms in a Portuguese population sample. Cell Biochem Funct 27:251–255. https://doi.org/10.1002/cbf.1561",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cpt.2149",
      "author": "KR Crews",
      "doi-asserted-by": "publisher",
      "first-page": "888",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR35",
      "unstructured": "Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, Dunnenberger HM, Leeder JS, Callaghan JT, Samer CF, Klein TE, Haidar CE, van Driest SL, Ruano G, Sangkuhl K, Cavallari LH, Müller DJ, Prows CA, Nagy M, Somogyi AA, Skaar TC (2021) Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther 110:888–896. https://doi.org/10.1002/cpt.2149",
      "volume": "110",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s002280100282",
      "author": "C Dandara",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "2385_CR36",
      "unstructured": "Dandara C, Masimirembwa CM, Magimba A, Sayi J, Kaaya S, Sommers DK, Snyman JR, Hasler JA (2001) Genetic polymorphism of CYP2D6 and CYP2C19 in east- and southern African populations including psychiatric patients. Eur J Clin Pharmacol 57:11–17. https://doi.org/10.1007/s002280100282",
      "volume": "57",
      "year": "2001"
    },
    {
      "author": "C De Araujo",
      "first-page": "262",
      "journal-title": "Haematologica",
      "key": "2385_CR37",
      "unstructured": "De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R (2006) The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal. Haematologica 91:262–263",
      "volume": "91",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jcf.2013.12.003",
      "author": "K De Boeck",
      "doi-asserted-by": "publisher",
      "first-page": "403",
      "journal-title": "J Cyst Fibros",
      "key": "2385_CR38",
      "unstructured": "De Boeck K, Zolin A, Cuppens H, Olesen HV, Viviani L (2014) The relative frequency of CFTR mutation classes in European patients with cystic fibrosis. J Cyst Fibros 13:403–409. https://doi.org/10.1016/j.jcf.2013.12.003",
      "volume": "13",
      "year": "2014"
    },
    {
      "DOI": "10.4084/MJHID.2021.029",
      "author": "S Dechyotin",
      "doi-asserted-by": "publisher",
      "journal-title": "Mediterr J Hematol Infect Dis",
      "key": "2385_CR39",
      "unstructured": "Dechyotin S, Sakunthai K, Khemtonglang N, Yamsri S, Sanchaisuriya K, Kitcharoen K, Kitcharoen S (2021) Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in females from previously malaria endemic regions in Northeastern Thailand and identification of a novel G6PD variant. Mediterr J Hematol Infect Dis 13:e2021029. https://doi.org/10.4084/MJHID.2021.029",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.meegid.2020.104597",
      "author": "R Devendra",
      "doi-asserted-by": "publisher",
      "journal-title": "Infect Genet Evol",
      "key": "2385_CR40",
      "unstructured": "Devendra R, Gupta V, Shanmugam R, Singh M, Patel P, Valecha N, Mishra N, Ahmed N, Hoti SL, Hegde HV, Warang P, Chiddarwar A, Kedar P, Mayekar P, Mukherjee MB (2020) Prevalence and spectrum of mutations causing G6PD deficiency in Indian populations. Infect Genet Evol 86:104597. https://doi.org/10.1016/j.meegid.2020.104597",
      "volume": "86",
      "year": "2020"
    },
    {
      "DOI": "10.1038/tpj.2015.76",
      "author": "TM Dodgen",
      "doi-asserted-by": "publisher",
      "first-page": "566",
      "journal-title": "Pharmacogenom J",
      "key": "2385_CR41",
      "unstructured": "Dodgen TM, Labuschagne CJ, van Schalkwyk A, Steffens FE, Gaedigk A, Cromarty AD, Alessandrini M, Pepper MS (2016) Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort. Pharmacogenom J 16:566–572. https://doi.org/10.1038/tpj.2015.76",
      "volume": "16",
      "year": "2016"
    },
    {
      "DOI": "10.1111/jcpt.12835",
      "author": "PW Dorji",
      "doi-asserted-by": "publisher",
      "first-page": "508",
      "journal-title": "J Clin Pharm Ther",
      "key": "2385_CR42",
      "unstructured": "Dorji PW, Tshering G, Na-Bangchang K (2019) CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in south-east and east Asian populations: a systematic review. J Clin Pharm Ther 44:508–524. https://doi.org/10.1111/jcpt.12835",
      "volume": "44",
      "year": "2019"
    },
    {
      "DOI": "10.1038/srep37284",
      "author": "CG Doss",
      "doi-asserted-by": "publisher",
      "first-page": "37284",
      "journal-title": "Sci Rep",
      "key": "2385_CR43",
      "unstructured": "Doss CG, Alasmar DR, Bux RI, Sneha P, Bakhsh FD, Al-Azwani I, Bekay RE, Zayed H (2016) Genetic epidemiology of glucose-6-phosphate dehydrogenase deficiency in the arab world. Sci Rep 6:37284. https://doi.org/10.1038/srep37284",
      "volume": "6",
      "year": "2016"
    },
    {
      "DOI": "10.2217/pgs.10.90",
      "author": "BI Drögemöller",
      "doi-asserted-by": "publisher",
      "first-page": "1095",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR44",
      "unstructured": "Drögemöller BI, Wright GE, Niehaus DJ, Koen L, Malan S, Da Silva DM, Hillermann-Rebello R, La Grange AM, Venter M, Warnich L (2010) Characterization of the genetic profile of CYP2C19 in two South African populations. Pharmacogenomics 11:1095–1103. https://doi.org/10.2217/pgs.10.90",
      "volume": "11",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cpt.531",
      "author": "T Elraiyah",
      "doi-asserted-by": "publisher",
      "first-page": "382",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR45",
      "unstructured": "Elraiyah T, Jerde CR, Shrestha S, Wu R, Nie Q, Giama NH, Sarangi V, Roberts LR, Offer SM, Diasio RB (2017) Novel deleterious dihydropyrimidine dehydrogenase variants may contribute to 5-fluorouracil sensitivity in an east African population. Clin Pharmacol Ther 101:382–390. https://doi.org/10.1002/cpt.531",
      "volume": "101",
      "year": "2017"
    },
    {
      "DOI": "10.3816/ccc.2004.n.018",
      "author": "H Ezzeldin",
      "doi-asserted-by": "publisher",
      "first-page": "181",
      "journal-title": "Clin Colorectal Cancer",
      "key": "2385_CR46",
      "unstructured": "Ezzeldin H, Diasio R (2004) Dihydropyrimidine dehydrogenase deficiency, a pharmacogenetic syndrome associated with potentially life-threatening toxicity following 5-fluorouracil administration. Clin Colorectal Cancer 4:181–189. https://doi.org/10.3816/ccc.2004.n.018",
      "volume": "4",
      "year": "2004"
    },
    {
      "DOI": "10.1097/fpc.0000000000000411",
      "author": "GMA Ferreira",
      "doi-asserted-by": "publisher",
      "first-page": "184",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2385_CR47",
      "unstructured": "Ferreira GMA, Ribeiro Elias AB, Nascimento J, Monteiro WM, Melo GC, Baia-da-Silva DC, Lacerda MVG, Suarez-Kurtz G (2020) Pharmacogenomics of thiopurines: distribution of TPMT and NUDT15 polymorphisms in the Brazilian Amazon. Pharmacogenet Genomics 30:184–189. https://doi.org/10.1097/fpc.0000000000000411",
      "volume": "30",
      "year": "2020"
    },
    {
      "DOI": "10.1371/journal.pone.0110691",
      "author": "DC Friedrich",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR48",
      "unstructured": "Friedrich DC, Genro JP, Sortica VA, Suarez-Kurtz G, de Moraes ME, Pena SD, dos Santos AK, Romano-Silva MA, Hutz MH (2014) Distribution of CYP2D6 alleles and phenotypes in the Brazilian population. PLoS ONE 9:e110691. https://doi.org/10.1371/journal.pone.0110691",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.1097/fpc.0000000000000172",
      "author": "K Fujikura",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2385_CR49",
      "unstructured": "Fujikura K, Ingelman-Sundberg M, Lauschke VM (2015) Genetic variation in the human cytochrome P450 supergene family. Pharmacogenet Genomics 25:584–594. https://doi.org/10.1097/fpc.0000000000000172",
      "volume": "25",
      "year": "2015"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201243",
      "author": "S Fuselli",
      "doi-asserted-by": "publisher",
      "first-page": "916",
      "journal-title": "Eur J Hum Genet",
      "key": "2385_CR50",
      "unstructured": "Fuselli S, Dupanloup I, Frigato E, Cruciani F, Scozzari R, Moral P, Sistonen J, Sajantila A, Barbujani G (2004) Molecular diversity at the CYP2D6 locus in the Mediterranean region. Eur J Hum Genet 12:916–924. https://doi.org/10.1038/sj.ejhg.5201243",
      "volume": "12",
      "year": "2004"
    },
    {
      "DOI": "10.1038/gim.2016.80",
      "author": "A Gaedigk",
      "doi-asserted-by": "publisher",
      "first-page": "69",
      "journal-title": "Genet Med",
      "key": "2385_CR51",
      "unstructured": "Gaedigk A, Sangkuhl K, Whirl-Carrillo M, Klein T, Leeder JS (2017) Prediction of CYP2D6 phenotype from genotype across world populations. Genet Med 19:69–76. https://doi.org/10.1038/gim.2016.80",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1515/dmpt-2016-0024",
      "author": "L Ganoci",
      "doi-asserted-by": "publisher",
      "first-page": "11",
      "journal-title": "Drug Metab Pers Ther",
      "key": "2385_CR52",
      "unstructured": "Ganoci L, Božina T, Mirošević Skvrce N, Lovrić M, Mas P, Božina N (2017) Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population. Drug Metab Pers Ther 32:11–21. https://doi.org/10.1515/dmpt-2016-0024",
      "volume": "32",
      "year": "2017"
    },
    {
      "author": "M Ganzcakowski",
      "first-page": "294",
      "journal-title": "Am J Hum Genet",
      "key": "2385_CR53",
      "unstructured": "Ganzcakowski M, Town M, Bowden DK, Vulliamy TJ, Kaneko A, Clegg JB, Weatherall DJ, Luzzatto L (1995) Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am J Hum Genet 56:294–301",
      "volume": "56",
      "year": "1995"
    },
    {
      "DOI": "10.1007/s00228-012-1252-3",
      "author": "B Gawrońska-Szklarz",
      "doi-asserted-by": "publisher",
      "first-page": "1267",
      "journal-title": "Eur J Clin Pharmacol",
      "key": "2385_CR54",
      "unstructured": "Gawrońska-Szklarz B, Adamiak-Giera U, Wyska E, Kurzawski M, Gornik W, Kaldonska M, Drozdzik M (2012) CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers. Eur J Clin Pharmacol 68:1267–1274. https://doi.org/10.1007/s00228-012-1252-3",
      "volume": "68",
      "year": "2012"
    },
    {
      "DOI": "10.1038/tpj.2013.40",
      "author": "E Genin",
      "doi-asserted-by": "publisher",
      "first-page": "281",
      "journal-title": "Pharmacogenom J",
      "key": "2385_CR55",
      "unstructured": "Genin E, Chen DP, Hung SI, Sekula P, Schumacher M, Chang PY, Tsai SH, Wu TL, Bellón T, Tamouza R, Fortier C, Toubert A, Charron D, Hovnanian A, Wolkenstein P, Chung WH, Mockenhaupt M, Roujeau JC (2014) HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis. Pharmacogenom J 14:281–288. https://doi.org/10.1038/tpj.2013.40",
      "volume": "14",
      "year": "2014"
    },
    {
      "DOI": "10.1002/cpt.1007",
      "author": "MP Goetz",
      "doi-asserted-by": "publisher",
      "first-page": "770",
      "journal-title": "Clin Phamracol Ther",
      "key": "2385_CR56",
      "unstructured": "Goetz MP, Sangkuhl K, Guchelaar H-J, Schwab M, Province M, Whirl-Carrillo M, Symmans WF, McLeod HL, Ratain MJ, Zembutsu H, Gaedigk A, van Schaik RH, Ingle JN, Caudle KE, Klein TE (2018) Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy. Clin Phamracol Ther 103:770–777. https://doi.org/10.1002/cpt.1007",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1034/j.1399-0004.2001.590106.x",
      "author": "A Goldman",
      "doi-asserted-by": "publisher",
      "first-page": "37",
      "journal-title": "Clin Genet",
      "key": "2385_CR57",
      "unstructured": "Goldman A, Labrum R, Claustres M, Desgeorges M, Guittard C, Wallace A, Ramsay M (2001) The molecular basis of cystic fibrosis in South Africa. Clin Genet 59:37–41. https://doi.org/10.1034/j.1399-0004.2001.590106.x",
      "volume": "59",
      "year": "2001"
    },
    {
      "DOI": "10.1097/00008571-199912000-00006",
      "author": "EU Griese",
      "doi-asserted-by": "publisher",
      "first-page": "715",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR58",
      "unstructured": "Griese EU, Asante-Poku S, Ofori-Adjei D, Mikus G, Eichelbaum M (1999) Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population. Pharmacogenetics 9:715–723",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00008571-199910000-00006",
      "author": "D Hall",
      "doi-asserted-by": "publisher",
      "first-page": "591",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR59",
      "unstructured": "Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A (1999) Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics 9:591–599",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1046/j.1365-2125.2003.01786.x",
      "author": "SI Hamdy",
      "doi-asserted-by": "publisher",
      "first-page": "560",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2385_CR60",
      "unstructured": "Hamdy SI, Hiratsuka M, Narahara K, Endo N, El-Enany M, Moursi N, Ahmed MS, Mizugaki M (2003) Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population. Br J Clin Pharmacol 55:560–569. https://doi.org/10.1046/j.1365-2125.2003.01786.x",
      "volume": "55",
      "year": "2003"
    },
    {
      "DOI": "10.1136/bmjgh-2019-EDC.164",
      "author": "MMA Hamid",
      "doi-asserted-by": "publisher",
      "first-page": "A62",
      "journal-title": "BMJ Glob Health",
      "key": "2385_CR61",
      "unstructured": "Hamid MMA, Albsheer M, Muneer M, Altinae L, Lover AA (2019) PO 8609 Prevalence and risk factors for glucose-6-phosphate dehydrogenase (G6PD) deficiency in two P. vivax malaria-endemic areas in Sudan. BMJ Glob Health 4:A62. https://doi.org/10.1136/bmjgh-2019-EDC.164",
      "volume": "4",
      "year": "2019"
    },
    {
      "DOI": "10.2217/pgs-2017-0101",
      "author": "JM Hariprakash",
      "doi-asserted-by": "publisher",
      "first-page": "227",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR62",
      "unstructured": "Hariprakash JM, Vellarikkal SK, Keechilat P, Verma A, Jayarajan R, Dixit V, Ravi R, Senthivel V, Kumar A, Sehgal P, Sonakar AK, Ambawat S, Giri AK, Philip A, Sivadas A, Faruq M, Bharadwaj D, Sivasubbu S, Scaria V (2018) Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data. Pharmacogenomics 19:227–241. https://doi.org/10.2217/pgs-2017-0101",
      "volume": "19",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41598-020-74200-y",
      "author": "Y He",
      "doi-asserted-by": "publisher",
      "first-page": "17106",
      "journal-title": "Sci Rep",
      "key": "2385_CR63",
      "unstructured": "He Y, Zhang Y, Chen X, Wang Q, Ling L, Xu Y (2020) Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution. Sci Rep 10:17106. https://doi.org/10.1038/s41598-020-74200-y",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1111/bcp.13045",
      "author": "NA Helsby",
      "doi-asserted-by": "publisher",
      "first-page": "1303",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2385_CR64",
      "unstructured": "Helsby NA (2016) CYP2C19 and CYP2D6 genotypes in Pacific peoples. Br J Clin Pharmacol 82:1303–1307. https://doi.org/10.1111/bcp.13045",
      "volume": "82",
      "year": "2016"
    },
    {
      "DOI": "10.1002/hep.26425",
      "author": "E Herraez",
      "doi-asserted-by": "publisher",
      "first-page": "1065",
      "journal-title": "Hepatology",
      "key": "2385_CR65",
      "unstructured": "Herraez E, Lozano E, Macias RI, Vaquero J, Bujanda L, Banales JM, Marin JJ, Briz O (2013) Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib. Hepatology 58:1065–1073. https://doi.org/10.1002/hep.26425",
      "volume": "58",
      "year": "2013"
    },
    {
      "DOI": "10.1016/s0149-2918(01)80132-6",
      "author": "S Hetherington",
      "doi-asserted-by": "publisher",
      "first-page": "1603",
      "journal-title": "Clin Ther",
      "key": "2385_CR66",
      "unstructured": "Hetherington S, McGuirk S, Powell G, Cutrell A, Naderer O, Spreen B, Lafon S, Pearce G, Steel H (2001) Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir. Clin Ther 23:1603–1614. https://doi.org/10.1016/s0149-2918(01)80132-6",
      "volume": "23",
      "year": "2001"
    },
    {
      "DOI": "10.1016/s0027-5107(00)00004-x",
      "author": "M Hiratsuka",
      "doi-asserted-by": "publisher",
      "first-page": "91",
      "journal-title": "Mutat Res",
      "key": "2385_CR67",
      "unstructured": "Hiratsuka M, Inoue T, Omori F, Agatsuma Y, Mizugaki M (2000) Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 448:91–95. https://doi.org/10.1016/s0027-5107(00)00004-x",
      "volume": "448",
      "year": "2000"
    },
    {
      "DOI": "10.1200/jco.2001.19.8.2282",
      "author": "PM Hoff",
      "doi-asserted-by": "publisher",
      "first-page": "2282",
      "journal-title": "J Clin Oncol",
      "key": "2385_CR68",
      "unstructured": "Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO, Wong R (2001) Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19:2282–2292. https://doi.org/10.1200/jco.2001.19.8.2282",
      "volume": "19",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/8.2.371",
      "author": "YY Hon",
      "doi-asserted-by": "publisher",
      "first-page": "371",
      "journal-title": "Hum Mol Genet",
      "key": "2385_CR69",
      "unstructured": "Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE (1999) Polymorphism of the thiopurine S-methyltransferase gene in African–Americans. Hum Mol Genet 8:371–376. https://doi.org/10.1093/hmg/8.2.371",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1186/1475-2875-12-418",
      "author": "RE Howes",
      "doi-asserted-by": "publisher",
      "first-page": "418",
      "journal-title": "Malar J",
      "key": "2385_CR70",
      "unstructured": "Howes RE, Dewi M, Piel FB, Monteiro WM, Battle KE, Messina JP, Sakuntabhai A, Satyagraha AW, Williams TN, Baird JK, Hay SI (2013) Spatial distribution of G6PD deficiency variants across malaria-endemic regions. Malar J 12:418. https://doi.org/10.1186/1475-2875-12-418",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.0409500102",
      "author": "SI Hung",
      "doi-asserted-by": "publisher",
      "first-page": "4134",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "2385_CR71",
      "unstructured": "Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102:4134–4139. https://doi.org/10.1073/pnas.0409500102",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1038/nature11147",
      "author": "PT Illing",
      "doi-asserted-by": "publisher",
      "first-page": "554",
      "journal-title": "Nature",
      "key": "2385_CR72",
      "unstructured": "Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486:554–558. https://doi.org/10.1038/nature11147",
      "volume": "486",
      "year": "2012"
    },
    {
      "author": "H Inamochi",
      "first-page": "417",
      "journal-title": "J Exp Clin Cancer Res",
      "key": "2385_CR73",
      "unstructured": "Inamochi H, Higashigawa M, Shimono Y, Nagata T, Cao DC, Mao XY, M’Soka T, Hori H, Kawasaki H, Sakurai M (1999) Delayed cytotoxicity of 6-mercaptopurine is compatible with mitotic death caused by DNA damage due to incorporation of 6-thioguanine into DNA as 6-thioguanine nucleotide. J Exp Clin Cancer Res 18:417–424",
      "volume": "18",
      "year": "1999"
    },
    {
      "DOI": "10.1038/sj.tpj.6500285",
      "author": "M Ingelman-Sundberg",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Pharmacogenom J",
      "key": "2385_CR74",
      "unstructured": "Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenom J 5:6–13. https://doi.org/10.1038/sj.tpj.6500285",
      "volume": "5",
      "year": "2005"
    },
    {
      "DOI": "10.1111/cts.12830",
      "author": "Y Ionova",
      "doi-asserted-by": "publisher",
      "first-page": "1298",
      "journal-title": "Clin Transl Sci",
      "key": "2385_CR75",
      "unstructured": "Ionova Y, Ashenhurst J, Zhan J, Nhan H, Kosinski C, Tamraz B, Chubb A (2020) CYP2C19 allele frequencies in over 2.2 million direct-to-consumer genetics research participants and the potential implication for prescriptions in a large health system. Clin Transl Sci 13:1298–1306. https://doi.org/10.1111/cts.12830",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1358/mf.2000.22.9.802286",
      "author": "CA Isaza",
      "doi-asserted-by": "publisher",
      "first-page": "695",
      "journal-title": "Methods Find Exp Clin Pharmacol",
      "key": "2385_CR76",
      "unstructured": "Isaza CA, Henao J, López AM, Cacabelos R (2000) Isolation, sequence and genotyping of the drug metabolizer CYP2D6 gene in the Colombian population. Methods Find Exp Clin Pharmacol 22:695–705. https://doi.org/10.1358/mf.2000.22.9.802286",
      "volume": "22",
      "year": "2000"
    },
    {
      "DOI": "10.1358/mf.2003.25.6.769646",
      "author": "C Isaza",
      "doi-asserted-by": "publisher",
      "first-page": "423",
      "journal-title": "Methods Find Exp Clin Pharmacol",
      "key": "2385_CR77",
      "unstructured": "Isaza C, Henao J, López AM, Cacabelos R (2003) Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find Exp Clin Pharmacol 25:423–429. https://doi.org/10.1358/mf.2003.25.6.769646",
      "volume": "25",
      "year": "2003"
    },
    {
      "DOI": "10.1007/s10038-008-0294-y",
      "author": "A Jalloh",
      "doi-asserted-by": "publisher",
      "first-page": "675",
      "journal-title": "J Hum Genet",
      "key": "2385_CR78",
      "unstructured": "Jalloh A, Jalloh M, Gamanga I, Baion D, Sahr F, Gbakima A, Willoughby VR, Matsuoka H (2008) G6PD deficiency assessment in Freetown, Sierra Leone, reveals further insight into the molecular heterogeneity of G6PD A. J Hum Genet 53:675–679. https://doi.org/10.1007/s10038-008-0294-y",
      "volume": "53",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0088605",
      "author": "N Jamornthanyawat",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR79",
      "unstructured": "Jamornthanyawat N, Awab GR, Tanomsing N, Pukrittayakamee S, Yamin F, Dondorp AM, Day NP, White NJ, Woodrow CJ, Imwong M (2014) A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C\u003eT (Mediterranean) mutation in Afghanistan. PLoS ONE 9:e88605. https://doi.org/10.1371/journal.pone.0088605",
      "volume": "9",
      "year": "2014"
    },
    {
      "DOI": "10.31557/apjcp.2019.20.3.801",
      "author": "YB Jarrar",
      "doi-asserted-by": "publisher",
      "first-page": "801",
      "journal-title": "Asian Pac J Cancer Prev",
      "key": "2385_CR80",
      "unstructured": "Jarrar YB, Ghishan M (2019) The nudix hydrolase 15 (nudt15) gene variants among Jordanian Arab population. Asian Pac J Cancer Prev 20:801–808. https://doi.org/10.31557/apjcp.2019.20.3.801",
      "volume": "20",
      "year": "2019"
    },
    {
      "DOI": "10.1371/journal.pone.0007246",
      "author": "MK Johnson",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR81",
      "unstructured": "Johnson MK, Clark TD, Njama-Meya D, Rosenthal PJ, Parikh S (2009) Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility. PLoS ONE 4:e7246. https://doi.org/10.1371/journal.pone.0007246",
      "volume": "4",
      "year": "2009"
    },
    {
      "author": "LF Jorge",
      "first-page": "217",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR82",
      "unstructured": "Jorge LF, Eichelbaum M, Griese EU, Inaba T, Arias TD (1999) Comparative evolutionary pharmacogenetics of CYP2D6 in Ngawbe and Embera Amerindians of Panama and Colombia: role of selection versus drift in world populations. Pharmacogenetics 9:217–228",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1016/s0140-6736(05)62696-7",
      "author": "A Kaneko",
      "doi-asserted-by": "publisher",
      "first-page": "921",
      "journal-title": "Lancet",
      "key": "2385_CR83",
      "unstructured": "Kaneko A, Kaneko O, Taleo G, Björkman A, Kobayakawa T (1997) High frequencies of CYP2C19 mutations and poor metabolism of proguanil in Vanuatu. Lancet 349:921–922. https://doi.org/10.1016/s0140-6736(05)62696-7",
      "volume": "349",
      "year": "1997"
    },
    {
      "DOI": "10.1097/01213011-199910000-00005",
      "author": "A Kaneko",
      "doi-asserted-by": "publisher",
      "first-page": "581",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR84",
      "unstructured": "Kaneko A, Lum JK, Yaviong L, Takahashi N, Ishizaki T, Bertilsson L, Kobayakawa T, Björkman A (1999) High and variable frequencies of CYP2C19 mutations: medical consequences of poor drug metabolism in Vanuatu and other Pacific islands. Pharmacogenetics 9:581–590",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.bbrc.2013.06.067",
      "author": "H Karim",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "journal-title": "Biochem Biophys Res Commun",
      "key": "2385_CR85",
      "unstructured": "Karim H, Ghalali A, Lafolie P, Vitols S, Fotoohi AK (2013) Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells. Biochem Biophys Res Commun 437:280–286. https://doi.org/10.1016/j.bbrc.2013.06.067",
      "volume": "437",
      "year": "2013"
    },
    {
      "author": "M Karimi",
      "first-page": "346",
      "journal-title": "Haematologica",
      "key": "2385_CR86",
      "unstructured": "Karimi M, Martinez di Montemuros F, Danielli MG, Farjadian S, Afrasiabi A, Fiorelli G, Cappellini MD (2003) Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Fars province of Iran. Haematologica 88:346–347",
      "volume": "88",
      "year": "2003"
    },
    {
      "DOI": "10.1080/13543784.2020.1828862",
      "author": "E Kerem",
      "doi-asserted-by": "publisher",
      "first-page": "1347",
      "journal-title": "Expert Opin Investig Drugs",
      "key": "2385_CR87",
      "unstructured": "Kerem E (2020) ELX-02: an investigational read-through agent for the treatment of nonsense mutation-related genetic disease. Expert Opin Investig Drugs 29:1347–1354. https://doi.org/10.1080/13543784.2020.1828862",
      "volume": "29",
      "year": "2020"
    },
    {
      "DOI": "10.4103/jrms.JRMS_1076_18",
      "author": "Z Khalaj",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "journal-title": "J Res Med Sci",
      "key": "2385_CR88",
      "unstructured": "Khalaj Z, Baratieh Z, Nikpour P, Khanahmad H, Mokarian F, Salehi R, Salehi M (2019) Distribution of CYP2D6 polymorphism in the Middle Eastern region. J Res Med Sci 24:61. https://doi.org/10.4103/jrms.JRMS_1076_18",
      "volume": "24",
      "year": "2019"
    },
    {
      "DOI": "10.1097/00043426-200206000-00006",
      "author": "SK Kham",
      "doi-asserted-by": "publisher",
      "first-page": "353",
      "journal-title": "J Pediatr Hematol Oncol",
      "key": "2385_CR89",
      "unstructured": "Kham SK, Tan PL, Tay AH, Heng CK, Yeoh AE, Quah TC (2002) Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 24:353–359. https://doi.org/10.1097/00043426-200206000-00006",
      "volume": "24",
      "year": "2002"
    },
    {
      "DOI": "10.1097/fpc.0000000000000274",
      "author": "HT Kim",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2385_CR90",
      "unstructured": "Kim HT, Choi R, Won HH, Choe YH, Kang B, Lee K, Koo HH, Yoo KH, Kim YH, Lee SY (2017) NUDT15 genotype distributions in the Korean population. Pharmacogenet Genomics 27:197–200. https://doi.org/10.1097/fpc.0000000000000274",
      "volume": "27",
      "year": "2017"
    },
    {
      "DOI": "10.2217/pgs.09.76",
      "author": "FB Kohlrausch",
      "doi-asserted-by": "publisher",
      "first-page": "1457",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR91",
      "unstructured": "Kohlrausch FB, Gama CS, Lobato MI, Belmonte-de-Abreu P, Gesteira A, Barros F, Carracedo A, Hutz MH (2009) Molecular diversity at the CYP2D6 locus in healthy and schizophrenic southern Brazilians. Pharmacogenomics 10:1457–1466. https://doi.org/10.2217/pgs.09.76",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1038/s41398-020-01129-1",
      "author": "AB Koopmans",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "journal-title": "Transl Psychiatry",
      "key": "2385_CR92",
      "unstructured": "Koopmans AB, Braakman MH, Vinkers DJ, Hoek HW, van Harten PN (2021) Meta-analysis of probability estimates of worldwide variation of CYP2D6 and CYP2C19. Transl Psychiatry 11:141. https://doi.org/10.1038/s41398-020-01129-1",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.phrs.2021.105904",
      "author": "M Koromina",
      "doi-asserted-by": "publisher",
      "journal-title": "Pharmacol Res",
      "key": "2385_CR93",
      "unstructured": "Koromina M, Pandi MT, van der Spek PJ, Patrinos GP, Lauschke VM (2021) The ethnogeographic variability of genetic factors underlying G6PD deficiency. Pharmacol Res 173:105904. https://doi.org/10.1016/j.phrs.2021.105904",
      "volume": "173",
      "year": "2021"
    },
    {
      "DOI": "10.1002/humu.24018",
      "author": "F Kounelis",
      "doi-asserted-by": "publisher",
      "first-page": "1112",
      "journal-title": "Hum Mutat",
      "key": "2385_CR94",
      "unstructured": "Kounelis F, Kanterakis A, Kanavos A, Pandi MT, Kordou Z, Manusama O, Vonitsanos G, Katsila T, Tsermpini EE, Lauschke VM, Koromina M, van der Spek PJ, Patrinos GP (2020) Documentation of clinically relevant genomic biomarker allele frequencies in the next-generation FINDbase worldwide database. Hum Mutat 41:1112–1122. https://doi.org/10.1002/humu.24018",
      "volume": "41",
      "year": "2020"
    },
    {
      "DOI": "10.20471/ACC.2016.55.01.3",
      "author": "A Ladić",
      "doi-asserted-by": "publisher",
      "first-page": "16",
      "journal-title": "Acta Clin Croat",
      "key": "2385_CR95",
      "unstructured": "Ladić A, Božina N, Borzan V, Brinar M, Vucelić B, Cuković-Cavka S (2016) An epidemiological study of thiopurine-methyltransferase variants in a Croatian inflammatory bowel disease patient cohort. Acta Clin Croat 55:16–22. https://doi.org/10.20471/ACC.2016.55.01.3",
      "volume": "55",
      "year": "2016"
    },
    {
      "DOI": "10.3389/fgene.2021.692234",
      "author": "IM Langmia",
      "doi-asserted-by": "publisher",
      "journal-title": "Front Gen",
      "key": "2385_CR96",
      "unstructured": "Langmia IM, Just KS, Yamoune S, Brockmöller J, Masimirembwa C, Stingl JC (2021) CYP2B6 functional variability in drug metabolism and exposure across populations-implication for drug safety, dosing, and individualized therapy. Front Gen 12:692234. https://doi.org/10.3389/fgene.2021.692234",
      "volume": "12",
      "year": "2021"
    },
    {
      "DOI": "10.1258/000456303766477039",
      "author": "LE Laróvere",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "Ann Clin Biochem",
      "key": "2385_CR97",
      "unstructured": "Laróvere LE, de Kremer RD, Lambooy LH, De Abreu RA (2003) Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem 40:388–393. https://doi.org/10.1258/000456303766477039",
      "volume": "40",
      "year": "2003"
    },
    {
      "DOI": "10.2217/pgs-2016-0023",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "917",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR98",
      "unstructured": "Lauschke VM, Ingelman-Sundberg M (2016) Requirements for comprehensive pharmacogenetic genotyping platforms. Pharmacogenomics 17:917–924. https://doi.org/10.2217/pgs-2016-0023",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1208/s12248-017-0161-x",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "journal-title": "Aaps j",
      "key": "2385_CR99",
      "unstructured": "Lauschke VM, Milani L, Ingelman-Sundberg M (2017) Pharmacogenomic biomarkers for improved drug therapy-recent progress and future developments. Aaps j 20:4. https://doi.org/10.1208/s12248-017-0161-x",
      "volume": "20",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.pharmthera.2019.01.002",
      "author": "VM Lauschke",
      "doi-asserted-by": "publisher",
      "first-page": "122",
      "journal-title": "Pharmacol Ther",
      "key": "2385_CR100",
      "unstructured": "Lauschke VM, Zhou Y, Ingelman-Sundberg M (2019) Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity. Pharmacol Ther 197:122–152. https://doi.org/10.1016/j.pharmthera.2019.01.002",
      "volume": "197",
      "year": "2019"
    },
    {
      "DOI": "10.1001/jama.279.15.1200",
      "author": "J Lazarou",
      "doi-asserted-by": "publisher",
      "first-page": "1200",
      "journal-title": "JAMA",
      "key": "2385_CR101",
      "unstructured": "Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279:1200–1205. https://doi.org/10.1001/jama.279.15.1200",
      "volume": "279",
      "year": "1998"
    },
    {
      "DOI": "10.1016/j.cca.2008.08.014",
      "author": "SS Lee",
      "doi-asserted-by": "publisher",
      "first-page": "82",
      "journal-title": "Clin Chim Acta",
      "key": "2385_CR102",
      "unstructured": "Lee SS, Kim WY, Jang YJ, Shin JG (2008) Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations. Clin Chim Acta 398:82–85. https://doi.org/10.1016/j.cca.2008.08.014",
      "volume": "398",
      "year": "2008"
    },
    {
      "DOI": "10.1038/tpj.2010.85",
      "author": "A Llerena",
      "doi-asserted-by": "publisher",
      "first-page": "176",
      "journal-title": "Pharmacogenom J",
      "key": "2385_CR103",
      "unstructured": "Llerena A, Dorado P, Ramírez R, González I, Alvarez M, Peñas-Lledó EM, Pérez B, Calzadilla LR (2012) CYP2D6 genotype and debrisoquine hydroxylation phenotype in Cubans and Nicaraguans. Pharmacogenom J 12:176–183. https://doi.org/10.1038/tpj.2010.85",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1067/mcp.2001.117445",
      "author": "T Loennechen",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR104",
      "unstructured": "Loennechen T, Utsi E, Hartz I, Lysaa R, Kildalsen H, Aarbakke J (2001) Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern Norway. Clin Pharmacol Ther 70:183–188. https://doi.org/10.1067/mcp.2001.117445",
      "volume": "70",
      "year": "2001"
    },
    {
      "DOI": "10.1097/FPC.0b013e3282f3ef9c",
      "author": "C Lonjou",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Pharmacogenet Genom",
      "key": "2385_CR105",
      "unstructured": "Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M (2008) A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genom 18:99–107. https://doi.org/10.1097/FPC.0b013e3282f3ef9c",
      "volume": "18",
      "year": "2008"
    },
    {
      "DOI": "10.2165/00129785-200404060-00006",
      "author": "HR Luo",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "journal-title": "Am J Pharmacogenom",
      "key": "2385_CR106",
      "unstructured": "Luo HR, Aloumanis V, Lin KM, Gurwitz D, Wan YJ (2004) Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups. Am J Pharmacogenom 4:395–401. https://doi.org/10.2165/00129785-200404060-00006",
      "volume": "4",
      "year": "2004"
    },
    {
      "author": "M Macek Jr",
      "first-page": "1122",
      "journal-title": "Am J Hum Genet",
      "key": "2385_CR107",
      "unstructured": "Macek M Jr, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G, Friedman KJ, Knowles MR, Rosenstein BJ, Cutting GR (1997) Identification of common cystic fibrosis mutations in African–Americans with cystic fibrosis increases the detection rate to 75%. Am J Hum Genet 60:1122–1127",
      "volume": "60",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJMoa0706135",
      "author": "S Mallal",
      "doi-asserted-by": "publisher",
      "first-page": "568",
      "journal-title": "N Engl J Med",
      "key": "2385_CR108",
      "unstructured": "Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568–579. https://doi.org/10.1056/NEJMoa0706135",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.1046/j.1365-2125.1996.00489.x",
      "author": "C Masimirembwa",
      "doi-asserted-by": "publisher",
      "first-page": "713",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2385_CR109",
      "unstructured": "Masimirembwa C, Persson I, Bertilsson L, Hasler J, Ingelman-Sundberg M (1996) A novel mutant variant of the CYP2D6 gene (CYP2D6*17) common in a black African population: association with diminished debrisoquine hydroxylase activity. Br J Clin Pharmacol 42:713–719. https://doi.org/10.1046/j.1365-2125.1996.00489.x",
      "volume": "42",
      "year": "1996"
    },
    {
      "DOI": "10.1007/s10038-004-0187-7",
      "author": "H Matsuoka",
      "doi-asserted-by": "publisher",
      "first-page": "544",
      "journal-title": "J Hum Genet",
      "key": "2385_CR110",
      "unstructured": "Matsuoka H, Wang J, Hirai M, Arai M, Yoshida S, Kobayashi T, Jalloh A, Lin K, Kawamoto F (2004) Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G\u003eA) is the most common variant in the Myanmar population. J Hum Genet 49:544–547. https://doi.org/10.1007/s10038-004-0187-7",
      "volume": "49",
      "year": "2004"
    },
    {
      "DOI": "10.1007/s10038-005-0279-z",
      "author": "H Matsuoka",
      "doi-asserted-by": "publisher",
      "first-page": "468",
      "journal-title": "J Hum Genet",
      "key": "2385_CR111",
      "unstructured": "Matsuoka H, Nguon C, Kanbe T, Jalloh A, Sato H, Yoshida S, Hirai M, Arai M, Socheat D, Kawamoto F (2005) Glucose-6-phosphate dehydrogenase (G6PD) mutations in Cambodia: G6PD Viangchan (871G\u003eA) is the most common variant in the Cambodian population. J Hum Genet 50:468–472. https://doi.org/10.1007/s10038-005-0279-z",
      "volume": "50",
      "year": "2005"
    },
    {
      "DOI": "10.1046/j.1365-3156.2000.00529.x",
      "author": "J May",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "journal-title": "Trop Med Int Health",
      "key": "2385_CR112",
      "unstructured": "May J, Meyer CG, Grossterlinden L, Ademowo OG, Mockenhaupt FP, Olumese PE, Falusi AG, Luzzatto L, Bienzle U (2000) Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 5:119–123. https://doi.org/10.1046/j.1365-3156.2000.00529.x",
      "volume": "5",
      "year": "2000"
    },
    {
      "DOI": "10.1097/00008571-199706000-00003",
      "author": "RA McLellan",
      "doi-asserted-by": "publisher",
      "first-page": "187",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR113",
      "unstructured": "McLellan RA, Oscarson M, Seidegård J, Evans DA, Ingelman-Sundberg M (1997) Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians. Pharmacogenetics 7:187–191. https://doi.org/10.1097/00008571-199706000-00003",
      "volume": "7",
      "year": "1997"
    },
    {
      "DOI": "10.1097/00008571-199912000-00012",
      "author": "HL McLeod",
      "doi-asserted-by": "publisher",
      "first-page": "773",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR114",
      "unstructured": "McLeod HL, Pritchard SC, Githang’a J, Indalo A, Ameyaw MM, Powrie RH, Booth L, Collie-Duguid ES (1999) Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 9:773–776. https://doi.org/10.1097/00008571-199912000-00012",
      "volume": "9",
      "year": "1999"
    },
    {
      "DOI": "10.1016/j.clinre.2011.12.001",
      "author": "S Melaouhia",
      "doi-asserted-by": "publisher",
      "first-page": "178",
      "journal-title": "Clin Res Hepatol Gastroenterol",
      "key": "2385_CR115",
      "unstructured": "Melaouhia S, Fékih M, Garat A, Allorge D, Ferchichi H, Klouz A, Boubaker J, Broly F, Lakhal M (2012) Allele frequency of inosine triphosphate pyrophosphatase (ITPA) and thiopurine-S-methyl transferase (TPMT) genes in the Tunisian population. Clin Res Hepatol Gastroenterol 36:178–184. https://doi.org/10.1016/j.clinre.2011.12.001",
      "volume": "36",
      "year": "2012"
    },
    {
      "DOI": "10.1046/j.1365-2141.2002.03483.x",
      "author": "SA Mesbah-Namin",
      "doi-asserted-by": "publisher",
      "first-page": "763",
      "journal-title": "Br J Haematol",
      "key": "2385_CR116",
      "unstructured": "Mesbah-Namin SA, Sanati MH, Mowjoodi A, Mason PJ, Vulliamy TJ, Noori-Saloii MR (2002) Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran. Br J Haematol 117:763–764. https://doi.org/10.1046/j.1365-2141.2002.03483.x",
      "volume": "117",
      "year": "2002"
    },
    {
      "DOI": "10.2217/pgs.12.52",
      "author": "L Mette",
      "doi-asserted-by": "publisher",
      "first-page": "803",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR117",
      "unstructured": "Mette L, Mitropoulos K, Vozikis A, Patrinos GP (2012) Pharmacogenomics and public health: implementing “populationalized” medicine. Pharmacogenomics 13:803–813. https://doi.org/10.2217/pgs.12.52",
      "volume": "13",
      "year": "2012"
    },
    {
      "DOI": "10.1371/journal.pone.0162866",
      "author": "C Mizzi",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR118",
      "unstructured": "Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M Jr, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Setric J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP (2016) A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics. PLoS ONE 11:e0162866. https://doi.org/10.1371/journal.pone.0162866",
      "volume": "11",
      "year": "2016"
    },
    {
      "DOI": "10.1067/mcp.2002.127396",
      "author": "E Molden",
      "doi-asserted-by": "publisher",
      "first-page": "333",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR119",
      "unstructured": "Molden E, Johansen PW, Bøe GH, Bergan S, Christensen H, Rugstad HE, Rootwelt H, Reubsaet L, Lehne G (2002) Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype. Clin Pharmacol Ther 72:333–342. https://doi.org/10.1067/mcp.2002.127396",
      "volume": "72",
      "year": "2002"
    },
    {
      "DOI": "10.2217/pgs.12.207",
      "author": "LK Montané Jaime",
      "doi-asserted-by": "publisher",
      "first-page": "261",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR120",
      "unstructured": "Montané Jaime LK, Lalla A, Steimer W, Gaedigk A (2013) Characterization of the CYP2D6 gene locus and metabolic activity in Indo- and Afro-Trinidadians: discovery of novel allelic variants. Pharmacogenomics 14:261–276. https://doi.org/10.2217/pgs.12.207",
      "volume": "14",
      "year": "2013"
    },
    {
      "DOI": "10.1038/ng.3508",
      "author": "T Moriyama",
      "doi-asserted-by": "publisher",
      "first-page": "367",
      "journal-title": "Nat Genet",
      "key": "2385_CR121",
      "unstructured": "Moriyama T, Nishii R, Perez-Andreu V, Yang W, Klussmann FA, Zhao X, Lin TN, Hoshitsuki K, Nersting J, Kihira K, Hofmann U, Komada Y, Kato M, McCorkle R, Li L, Koh K, Najera CR, Kham SK, Isobe T, Chen Z, Chiew EK, Bhojwani D, Jeffries C, Lu Y, Schwab M, Inaba H, Pui CH, Relling MV, Manabe A, Hori H, Schmiegelow K, Yeoh AE, Evans WE, Yang JJ (2016) NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity. Nat Genet 48:367–373. https://doi.org/10.1038/ng.3508",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.bcmd.2008.12.005",
      "author": "ET Nkhoma",
      "doi-asserted-by": "publisher",
      "first-page": "267",
      "journal-title": "Blood Cells Mol Dis",
      "key": "2385_CR122",
      "unstructured": "Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42:267–278. https://doi.org/10.1016/j.bcmd.2008.12.005",
      "volume": "42",
      "year": "2009"
    },
    {
      "DOI": "10.1038/clpt.2013.69",
      "author": "SM Offer",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR123",
      "unstructured": "Offer SM, Lee AM, Mattison LK, Fossum C, Wegner NJ, Diasio RB (2013) A DPYD variant (Y186C) in individuals of African ancestry is associated with reduced DPD enzyme activity. Clin Pharmacol Ther 94:158–166. https://doi.org/10.1038/clpt.2013.69",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1073/pnas.1207934109",
      "author": "DA Ostrov",
      "doi-asserted-by": "publisher",
      "first-page": "9959",
      "journal-title": "Proc Natl Acad Sci U S A",
      "key": "2385_CR124",
      "unstructured": "Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci U S A 109:9959–9964. https://doi.org/10.1073/pnas.1207934109",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.jcf.2019.09.007",
      "author": "SK Owusu",
      "doi-asserted-by": "publisher",
      "first-page": "540",
      "journal-title": "J Cyst Fibros",
      "key": "2385_CR125",
      "unstructured": "Owusu SK, Morrow BM, White D, Klugman S, Vanker A, Gray D, Zampoli M (2020) Cystic fibrosis in black African children in South Africa: a case control study. J Cyst Fibros 19:540–545. https://doi.org/10.1016/j.jcf.2019.09.007",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1146/annurev-med-050913-022745",
      "author": "R Pavlos",
      "doi-asserted-by": "publisher",
      "first-page": "439",
      "journal-title": "Annu Rev Med",
      "key": "2385_CR126",
      "unstructured": "Pavlos R, Mallal S, Ostrov D, Buus S, Metushi I, Peters B, Phillips E (2015) T cell-mediated hypersensitivity reactions to drugs. Annu Rev Med 66:439–454. https://doi.org/10.1146/annurev-med-050913-022745",
      "volume": "66",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.clpt.2005.01.014",
      "author": "RS Pedersen",
      "doi-asserted-by": "publisher",
      "first-page": "458",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR127",
      "unstructured": "Pedersen RS, Damkier P, Brosen K (2005) Tramadol as a new probe for cytochrome P450 2D6 phenotyping: a population study. Clin Pharmacol Ther 77:458–467. https://doi.org/10.1016/j.clpt.2005.01.014",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1128/aac.00275-21",
      "author": "L Pernaute-Lau",
      "doi-asserted-by": "publisher",
      "journal-title": "Antimicrob Agents Chemother",
      "key": "2385_CR128",
      "unstructured": "Pernaute-Lau L, Adegnika AA, Zhou Y, Zinsou JF, Gil JP, Krishna S, Kremsner PG, Lauschke VM, Velavan TP (2021) Pharmacogene sequencing of a gabonese population with severe plasmodium falciparum malaria reveals multiple novel variants with putative relevance for antimalarial treatment. Antimicrob Agents Chemother 65:e0027521. https://doi.org/10.1128/aac.00275-21",
      "volume": "65",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41431-019-0480-8",
      "author": "J Petrović",
      "doi-asserted-by": "publisher",
      "first-page": "88",
      "journal-title": "Eur J Hum Genet",
      "key": "2385_CR129",
      "unstructured": "Petrović J, Pešić V, Lauschke VM (2020) Frequencies of clinically important CYP2C19 and CYP2D6 alleles are graded across Europe. Eur J Hum Genet 28:88–94. https://doi.org/10.1038/s41431-019-0480-8",
      "volume": "28",
      "year": "2020"
    },
    {
      "DOI": "10.1111/bcp.12749",
      "author": "EJ Phillips",
      "doi-asserted-by": "publisher",
      "first-page": "10",
      "journal-title": "Br J Clin Pharmacol",
      "key": "2385_CR130",
      "unstructured": "Phillips EJ (2016) Classifying ADRs–does dose matter? Br J Clin Pharmacol 81:10–12. https://doi.org/10.1111/bcp.12749",
      "volume": "81",
      "year": "2016"
    },
    {
      "DOI": "10.1186/1475-2875-10-368",
      "author": "P Phompradit",
      "doi-asserted-by": "publisher",
      "first-page": "368",
      "journal-title": "Malar J",
      "key": "2385_CR131",
      "unstructured": "Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, Yamnuan R, Na-Bangchang K (2011) Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 10:368. https://doi.org/10.1186/1475-2875-10-368",
      "volume": "10",
      "year": "2011"
    },
    {
      "DOI": "10.1097/FPC.0b013e32835a3a6d",
      "author": "VN Pimenoff",
      "doi-asserted-by": "publisher",
      "first-page": "846",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2385_CR132",
      "unstructured": "Pimenoff VN, Laval G, Comas D, Palo JU, Gut I, Cann H, Excoffier L, Sajantila A (2012) Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates. Pharmacogenet Genomics 22:846–857. https://doi.org/10.1097/FPC.0b013e32835a3a6d",
      "volume": "22",
      "year": "2012"
    },
    {
      "DOI": "10.1136/bmj.329.7456.15",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "BMJ",
      "key": "2385_CR133",
      "unstructured": "Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 329:15–19. https://doi.org/10.1136/bmj.329.7456.15",
      "volume": "329",
      "year": "2004"
    },
    {
      "DOI": "10.4049/jimmunol.176.1.640",
      "author": "D Poppe",
      "doi-asserted-by": "publisher",
      "first-page": "640",
      "journal-title": "J Immunol",
      "key": "2385_CR134",
      "unstructured": "Poppe D, Tiede I, Fritz G, Becker C, Bartsch B, Wirtz S, Strand D, Tanaka S, Galle PR, Bustelo XR, Neurath MF (2006) Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol 176:640–651. https://doi.org/10.4049/jimmunol.176.1.640",
      "volume": "176",
      "year": "2006"
    },
    {
      "DOI": "10.1097/fpc.0000000000000381",
      "author": "FCP Poulussen",
      "doi-asserted-by": "publisher",
      "first-page": "179",
      "journal-title": "Pharmacogenet Genomics",
      "key": "2385_CR135",
      "unstructured": "Poulussen FCP, Peters BJ, Hua KH, Houthuizen P, Grouls RJ, Deenen MJ (2019) The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population. Pharmacogenet Genomics 29:179–182. https://doi.org/10.1097/fpc.0000000000000381",
      "volume": "29",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.ygeno.2008.05.004",
      "author": "S Qin",
      "doi-asserted-by": "publisher",
      "first-page": "152",
      "journal-title": "Genomics",
      "key": "2385_CR136",
      "unstructured": "Qin S, Shen L, Zhang A, Xie J, Shen W, Chen L, Tang J, Xiong Y, Yang L, Shi Y, Feng G, He L, Xing Q (2008) Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China. Genomics 92:152–158. https://doi.org/10.1016/j.ygeno.2008.05.004",
      "volume": "92",
      "year": "2008"
    },
    {
      "DOI": "10.1371/journal.pone.0028943",
      "author": "RY Qumsieh",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR137",
      "unstructured": "Qumsieh RY, Ali BR, Abdulrazzaq YM, Osman O, Akawi NA, Bastaki SM (2011) Identification of new alleles and the determination of alleles and genotypes frequencies at the CYP2D6 gene in Emiratis. PLoS ONE 6:e28943. https://doi.org/10.1371/journal.pone.0028943",
      "volume": "6",
      "year": "2011"
    },
    {
      "author": "M Raida",
      "first-page": "2832",
      "journal-title": "Clin Cancer Res",
      "key": "2385_CR138",
      "unstructured": "Raida M, Schwabe W, Häusler P, Van Kuilenburg AB, Van Gennip AH, Behnke D, Höffken K (2001) Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5’-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls. Clin Cancer Res 7:2832–2839",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1080/00365510500469702",
      "author": "JO Rasmussen",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "journal-title": "Scand J Clin Lab Investig",
      "key": "2385_CR139",
      "unstructured": "Rasmussen JO, Christensen M, Svendsen JM, Skausig O, Hansen EL, Nielsen KA (2006) CYP2D6 gene test in psychiatric patients and healthy volunteers. Scand J Clin Lab Investig 66:129–136. https://doi.org/10.1080/00365510500469702",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.jbc.2021.100568",
      "author": "D Rehling",
      "doi-asserted-by": "publisher",
      "journal-title": "J Biol Chem",
      "key": "2385_CR140",
      "unstructured": "Rehling D, Zhang SM, Jemth AS, Koolmeister T, Throup A, Wallner O, Scaletti E, Moriyama T, Nishii R, Davies J, Desroses M, Rudd SG, Scobie M, Homan E, Berglund UW, Yang JJ, Helleday T, Stenmark P (2021) Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity. J Biol Chem 296:100568. https://doi.org/10.1016/j.jbc.2021.100568",
      "volume": "296",
      "year": "2021"
    },
    {
      "DOI": "10.1038/clpt.2010.320",
      "author": "MV Relling",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR141",
      "unstructured": "Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW, Stein CM, Carrillo M, Evans WE, Klein TE (2011) Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. Clin Pharmacol Ther 89:387–391. https://doi.org/10.1038/clpt.2010.320",
      "volume": "89",
      "year": "2011"
    },
    {
      "DOI": "10.1186/s13073-021-00911-0",
      "author": "MC Roberts",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Genome Med",
      "key": "2385_CR142",
      "unstructured": "Roberts MC, Fohner AE, Landry L, Olstad DL, Smit AK, Turbitt E, Allen CG (2021) Advancing precision public health using human genomics: examples from the field and future research opportunities. Genome Med 13:97. https://doi.org/10.1186/s13073-021-00911-0",
      "volume": "13",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0231651",
      "author": "JCG Rodrigues",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR143",
      "unstructured": "Rodrigues JCG, Souza TP, Pastana LF, Ribeiro Dos Santos AM, Fernandes MR, Pinto P, Wanderley AV, Souza SJ, Kroll JE, Pereira AL, Magalhães L, Mercês LRD, Vidal AF, Vinasco-Sandoval T, Cavalcante GC, Guerreiro JF, Assumpção PP, Ribeiro-Dos-Santos Â, Santos S, Santos N (2020) Identification of NUDT15 gene variants in Amazonian Amerindians and admixed individuals from northern Brazil. PLoS ONE 15:e0231651. https://doi.org/10.1371/journal.pone.0231651",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.1111/j.1365-2710.2006.00736.x",
      "author": "R Rossino",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "journal-title": "J Clin Pharm Ther",
      "key": "2385_CR144",
      "unstructured": "Rossino R, Vincis C, Alves S, Prata MJ, Macis MD, Nucaro AL, Schirru E, Congia M (2006) Frequency of the thiopurine S-methyltransferase alleles in the ancient genetic population isolate of Sardinia. J Clin Pharm Ther 31:283–287. https://doi.org/10.1111/j.1365-2710.2006.00736.x",
      "volume": "31",
      "year": "2006"
    },
    {
      "DOI": "10.1080/03602532.2021.1909613",
      "author": "LE Russell",
      "doi-asserted-by": "publisher",
      "first-page": "253",
      "journal-title": "Drug Metab Rev",
      "key": "2385_CR145",
      "unstructured": "Russell LE, Zhou Y, Almousa AA, Sodhi JK, Nwabufo CK, Lauschke VM (2021) Pharmacogenomics in the era of next generation sequencing—from byte to bedside. Drug Metab Rev 53:253–278. https://doi.org/10.1080/03602532.2021.1909613",
      "volume": "53",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pone.0018507",
      "author": "A Sabbagh",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS ONE",
      "key": "2385_CR146",
      "unstructured": "Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES (2011) Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS ONE 6:e18507. https://doi.org/10.1371/journal.pone.0018507",
      "volume": "6",
      "year": "2011"
    },
    {
      "DOI": "10.1097/01.gim.0000118061.66602.a5",
      "author": "N Salgueiro",
      "doi-asserted-by": "publisher",
      "first-page": "102",
      "journal-title": "Genet Med",
      "key": "2385_CR147",
      "unstructured": "Salgueiro N, Veiga I, Fragoso M, Sousa O, Costa N, Pellon ML, Sanches E, dos Santos JG, Teixeira MR, Castedo S (2004) Mutations in exon 14 of dihydropyrimidine dehydrogenase and 5-Fluorouracil toxicity in Portuguese colorectal cancer patients. Genet Med 6:102–107. https://doi.org/10.1097/01.gim.0000118061.66602.a5",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.2165/00003495-199651040-00004",
      "author": "P Salvà Lacombe",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "journal-title": "Drugs",
      "key": "2385_CR148",
      "unstructured": "Salvà Lacombe P, García Vicente JA, Costa Pagès J, Lucio Morselli P (1996) Causes and problems of nonresponse or poor response to drugs. Drugs 51:552–570. https://doi.org/10.2165/00003495-199651040-00004",
      "volume": "51",
      "year": "1996"
    },
    {
      "DOI": "10.1186/s12936-020-03560-7",
      "author": "A Sanephonasa",
      "doi-asserted-by": "publisher",
      "first-page": "30",
      "journal-title": "Malar J",
      "key": "2385_CR149",
      "unstructured": "Sanephonasa A, Cheepsunthorn CL, Khaminsou N, Savongsy O, Nuchprayoon I, Leecharoenkiat K (2021) Molecular characterization of G6PD mutations reveals the high frequency of G6PD Aures in the Lao Theung population. Malar J 20:30. https://doi.org/10.1186/s12936-020-03560-7",
      "volume": "20",
      "year": "2021"
    },
    {
      "DOI": "10.1038/s41598-021-82477-w",
      "author": "LK SathupakS",
      "doi-asserted-by": "publisher",
      "first-page": "2956",
      "journal-title": "Sci Rep",
      "key": "2385_CR150",
      "unstructured": "SathupakS LK, Kampuansai J (2021) Prevalence and molecular characterization of glucose-6-phosphate dehydrogenase deficiency in the Lue ethnic group of northern Thailand. Sci Rep 11:2956. https://doi.org/10.1038/s41598-021-82477-w",
      "volume": "11",
      "year": "2021"
    },
    {
      "DOI": "10.1371/journal.pntd.0003602",
      "author": "AW Satyagraha",
      "doi-asserted-by": "publisher",
      "first-page": "e0003602",
      "journal-title": "PLoS Negl Trop Dis",
      "key": "2385_CR151",
      "unstructured": "Satyagraha AW, Sadhewa A, Baramuli V, Elvira R, Ridenour C, Elyazar I, Noviyanti R, Coutrier FN, Harahap AR, Baird JK (2015) PLoS Negl Trop Dis 9:e0003602. https://doi.org/10.1371/journal.pntd.0003602",
      "volume": "9",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pntd.0009610",
      "author": "AW Satyagraha",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Negl Trop Dis",
      "key": "2385_CR152",
      "unstructured": "Satyagraha AW, Sadhewa A, Panggalo LV, Subekti D, Elyazar I, Soebianto S, Mahpud N, Harahap AR, Baird JK (2021) Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria. PLoS Negl Trop Dis 15:e0009610. https://doi.org/10.1371/journal.pntd.0009610",
      "volume": "15",
      "year": "2021"
    },
    {
      "DOI": "10.1097/01.fpc.0000114745.08559.db",
      "author": "E Schaeffeler",
      "doi-asserted-by": "publisher",
      "first-page": "407",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR153",
      "unstructured": "Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger UM, Schwab M (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German–Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407–417. https://doi.org/10.1097/01.fpc.0000114745.08559.db",
      "volume": "14",
      "year": "2004"
    },
    {
      "DOI": "10.1038/s41436-019-0448-7",
      "author": "E Schaeffeler",
      "doi-asserted-by": "publisher",
      "first-page": "2145",
      "journal-title": "Genet Med",
      "key": "2385_CR154",
      "unstructured": "Schaeffeler E, Jaeger SU, Klumpp V, Yang JJ, Igel S, Hinze L, Stanulla M, Schwab M (2019) Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry. Genet Med 21:2145–2150. https://doi.org/10.1038/s41436-019-0448-7",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s00439-019-02081-x",
      "author": "L Schaller",
      "doi-asserted-by": "publisher",
      "first-page": "1359",
      "journal-title": "Hum Genet",
      "key": "2385_CR155",
      "unstructured": "Schaller L, Lauschke VM (2019) The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet 138:1359–1377. https://doi.org/10.1007/s00439-019-02081-x",
      "volume": "138",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jmoldx.2015.07.005",
      "author": "I Schrijver",
      "doi-asserted-by": "publisher",
      "first-page": "39",
      "journal-title": "J Mol Diagn",
      "key": "2385_CR156",
      "unstructured": "Schrijver I, Pique L, Graham S, Pearl M, Cherry A, Kharrazi M (2016) The spectrum of CFTR variants in nonwhite cystic fibrosis patients: implications for molecular diagnostic testing. J Mol Diagn 18:39–50. https://doi.org/10.1016/j.jmoldx.2015.07.005",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1097/00004630-200021030-00004",
      "author": "JT Schulz",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "journal-title": "J Burn Care Rehabil",
      "key": "2385_CR157",
      "unstructured": "Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG (2000) A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil 21:199–204. https://doi.org/10.1097/00004630-200021030-00004",
      "volume": "21",
      "year": "2000"
    },
    {
      "DOI": "10.2217/14622416.8.7.721",
      "author": "SA Scott",
      "doi-asserted-by": "publisher",
      "first-page": "721",
      "journal-title": "Pharmacogenomics",
      "key": "2385_CR158",
      "unstructured": "Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ (2007) CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Pharmacogenomics 8:721–730. https://doi.org/10.2217/14622416.8.7.721",
      "volume": "8",
      "year": "2007"
    },
    {
      "DOI": "10.1038/clpt.2013.105",
      "author": "SA Scott",
      "doi-asserted-by": "publisher",
      "first-page": "317",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR159",
      "unstructured": "Scott SA, Sangkuhl K, Stein CM, Hulot JS, Mega JL, Roden DM, Klein TE, Sabatine MS, Johnson JA, Shuldiner AR (2013) Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther 94:317–323. https://doi.org/10.1038/clpt.2013.105",
      "volume": "94",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13073-015-0172-0",
      "author": "T Seitz",
      "doi-asserted-by": "publisher",
      "first-page": "56",
      "journal-title": "Genome Med",
      "key": "2385_CR160",
      "unstructured": "Seitz T, Stalmann R, Dalila N, Chen J, Pojar S, Dos Santos Pereira JN, Krätzner R, Brockmöller J, Tzvetkov MV (2015) Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1. Genome Med 7:56. https://doi.org/10.1186/s13073-015-0172-0",
      "volume": "7",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.forsciint.2012.07.012",
      "author": "A Serin",
      "doi-asserted-by": "publisher",
      "first-page": "332",
      "journal-title": "Forensic Sci Int",
      "key": "2385_CR161",
      "unstructured": "Serin A, Canan H, Alper B, Gulmen M (2012) The frequencies of mutated alleles of CYP2D6 gene in a Turkish population. Forensic Sci Int 222:332–334. https://doi.org/10.1016/j.forsciint.2012.07.012",
      "volume": "222",
      "year": "2012"
    },
    {
      "DOI": "10.1515/dmpt-2017-0038",
      "author": "SAV Shah",
      "doi-asserted-by": "publisher",
      "first-page": "57",
      "journal-title": "Drug Metab Pers Ther",
      "key": "2385_CR162",
      "unstructured": "Shah SAV, Paradkar MU, Desai DC, Ashavaid TF (2018) Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity. Drug Metab Pers Ther 33:57–60. https://doi.org/10.1515/dmpt-2017-0038",
      "volume": "33",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.1720",
      "author": "R Shekhani",
      "doi-asserted-by": "publisher",
      "first-page": "1240",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR163",
      "unstructured": "Shekhani R, Steinacher L, Swen JJ, Ingelman-Sundberg M (2020) Evaluation of current regulation and guidelines of pharmacogenomic drug labels: opportunities for improvements. Clin Pharmacol Ther 107:1240–1255. https://doi.org/10.1002/cpt.1720",
      "volume": "107",
      "year": "2020"
    },
    {
      "DOI": "10.1007/s11033-013-2569-4",
      "author": "C Sipeky",
      "doi-asserted-by": "publisher",
      "first-page": "4727",
      "journal-title": "Mol Biol Rep",
      "key": "2385_CR164",
      "unstructured": "Sipeky C, Weber A, Szabo M, Melegh BI, Janicsek I, Tarlos G, Szabo I, Sumegi K, Melegh B (2013) High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature. Mol Biol Rep 40:4727–4735. https://doi.org/10.1007/s11033-013-2569-4",
      "volume": "40",
      "year": "2013"
    },
    {
      "DOI": "10.1097/01.fpc.0000239974.69464.f2",
      "author": "J Sistonen",
      "doi-asserted-by": "publisher",
      "first-page": "93",
      "journal-title": "Pharmacogenet Genom",
      "key": "2385_CR165",
      "unstructured": "Sistonen J, Sajantila A, Lao O, Corander J, Barbujani G, Fuselli S (2007) CYP2D6 worldwide genetic variation shows high frequency of altered activity variants and no continental structure. Pharmacogenet Genom 17:93–101. https://doi.org/10.1097/01.fpc.0000239974.69464.f2",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1097/FPC.0b013e32831ebb30",
      "author": "J Sistonen",
      "doi-asserted-by": "publisher",
      "first-page": "170",
      "journal-title": "Pharmacogenet Genom",
      "key": "2385_CR166",
      "unstructured": "Sistonen J, Fuselli S, Palo JU, Chauhan N, Padh H, Sajantila A (2009) Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales. Pharmacogenet Genom 19:170–179. https://doi.org/10.1097/FPC.0b013e32831ebb30",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.1002/cpt.1379",
      "author": "G Suarez-Kurtz",
      "doi-asserted-by": "publisher",
      "first-page": "1321",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR167",
      "unstructured": "Suarez-Kurtz G, Brisson GD, Hutz MH, Petzl-Erler ML, Salzano FM (2019) NUDT15 polymorphism in native American populations of Brazil. Clin Pharmacol Ther 105:1321–1322. https://doi.org/10.1002/cpt.1379",
      "volume": "105",
      "year": "2019"
    },
    {
      "author": "V Sulzyc-Bielicka",
      "first-page": "238",
      "journal-title": "Pharmacol Rep",
      "key": "2385_CR168",
      "unstructured": "Sulzyc-Bielicka V, Bińczak-Kuleta A, Pioch W, Kładny J, Gziut K, Bielicki D, Ciechanowicz A (2008) 5-Fluorouracil toxicity-attributable IVS14 + 1G \u003e A mutation of the dihydropyrimidine dehydrogenase gene in Polish colorectal cancer patients. Pharmacol Rep 60:238–242",
      "volume": "60",
      "year": "2008"
    },
    {
      "DOI": "10.1111/bjh.13518",
      "author": "Y Tanaka",
      "doi-asserted-by": "publisher",
      "first-page": "109",
      "journal-title": "Br J Haematol",
      "key": "2385_CR169",
      "unstructured": "Tanaka Y, Kato M, Hasegawa D, Urayama KY, Nakadate H, Kondoh K, Nakamura K, Koh K, Komiyama T, Manabe A (2015) Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia. Br J Haematol 171:109–115. https://doi.org/10.1111/bjh.13518",
      "volume": "171",
      "year": "2015"
    },
    {
      "DOI": "10.1046/j.1365-2710.2001.00347.x",
      "author": "LK Teh",
      "doi-asserted-by": "publisher",
      "first-page": "205",
      "journal-title": "J Clin Pharm Ther",
      "key": "2385_CR170",
      "unstructured": "Teh LK, Ismail R, Yusoff R, Hussein A, Isa MN, Rahman AR (2001) Heterogeneity of the CYP2D6 gene among Malays in Malaysia. J Clin Pharm Ther 26:205–211. https://doi.org/10.1046/j.1365-2710.2001.00347.x",
      "volume": "26",
      "year": "2001"
    },
    {
      "DOI": "10.1080/08035250600743788",
      "author": "N Toft",
      "doi-asserted-by": "publisher",
      "first-page": "1665",
      "journal-title": "Acta Paediatr",
      "key": "2385_CR171",
      "unstructured": "Toft N, Nygaard U, Gregers J, Schmiegelow K (2006) Genetic analyses of thiopurine methyltransferase polymorphisms in Greenlandic and Danish populations. Acta Paediatr 95:1665–1667. https://doi.org/10.1080/08035250600743788",
      "volume": "95",
      "year": "2006"
    },
    {
      "DOI": "10.1176/appi.ajp.163.1.28",
      "author": "MH Trivedi",
      "doi-asserted-by": "publisher",
      "first-page": "28",
      "journal-title": "Am J Psychiatry",
      "key": "2385_CR172",
      "unstructured": "Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28–40. https://doi.org/10.1176/appi.ajp.163.1.28",
      "volume": "163",
      "year": "2006"
    },
    {
      "DOI": "10.1038/clpt.2011.56",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "143",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR173",
      "unstructured": "Tzvetkov MV, Saadatmand AR, Lötsch J, Tegeder I, Stingl JC, Brockmöller J (2011) Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol. Clin Pharmacol Ther 90:143–150. https://doi.org/10.1038/clpt.2011.56",
      "volume": "90",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.bcp.2013.06.019",
      "author": "MV Tzvetkov",
      "doi-asserted-by": "publisher",
      "first-page": "666",
      "journal-title": "Biochem Pharmacol",
      "key": "2385_CR174",
      "unstructured": "Tzvetkov MV, dos Santos Pereira JN, Meineke I, Saadatmand AR, Stingl JC, Brockmöller J (2013) Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration. Biochem Pharmacol 86:666–678. https://doi.org/10.1016/j.bcp.2013.06.019",
      "volume": "86",
      "year": "2013"
    },
    {
      "DOI": "10.1124/pr.113.007450",
      "author": "J Uetrecht",
      "doi-asserted-by": "publisher",
      "first-page": "779",
      "journal-title": "Pharmacol Rev",
      "key": "2385_CR175",
      "unstructured": "Uetrecht J, Naisbitt DJ (2013) Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev 65:779–808. https://doi.org/10.1124/pr.113.007450",
      "volume": "65",
      "year": "2013"
    },
    {
      "author": "A Uzunkoy",
      "first-page": "3899",
      "journal-title": "Anticancer Res",
      "key": "2385_CR176",
      "unstructured": "Uzunkoy A, Dilmec F, Ozgonul A, van Kuilenburg AB, Akkafa F (2007) Investigation of IVS14+ 1G \u003e A polymorphism of DPYD gene in a group of Turkish patients with colorectal cancer. Anticancer Res 27:3899–3902",
      "volume": "27",
      "year": "2007"
    },
    {
      "DOI": "10.1200/jco.2001.19.21.4097",
      "author": "E Van Cutsem",
      "doi-asserted-by": "publisher",
      "first-page": "4097",
      "journal-title": "J Clin Oncol",
      "key": "2385_CR177",
      "unstructured": "Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P (2001) Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol 19:4097–4106. https://doi.org/10.1200/jco.2001.19.21.4097",
      "volume": "19",
      "year": "2001"
    },
    {
      "author": "AB van Kuilenburg",
      "first-page": "1149",
      "journal-title": "Clin Cancer Res",
      "key": "2385_CR178",
      "unstructured": "van Kuilenburg AB, Muller EW, Haasjes J, Meinsma R, Zoetekouw L, Waterham HR, Baas F, Richel DJ, van Gennip AH (2001) Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G\u003eA mutation causing DPD deficiency. Clin Cancer Res 7:1149–1153",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1007/s00439-010-0879-3",
      "author": "AB van Kuilenburg",
      "doi-asserted-by": "publisher",
      "first-page": "529",
      "journal-title": "Hum Genet",
      "key": "2385_CR179",
      "unstructured": "van Kuilenburg AB, Meijer J, Mul AN, Meinsma R, Schmid V, Dobritzsch D, Hennekam RC, Mannens MM, Kiechle M, Etienne-Grimaldi MC, Klümpen HJ, Maring JG, Derleyn VA, Maartense E, Milano G, Vijzelaar R, Gross E (2010) Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity. Hum Genet 128:529–538. https://doi.org/10.1007/s00439-010-0879-3",
      "volume": "128",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s11033-013-2971-y",
      "author": "J Vicente",
      "doi-asserted-by": "publisher",
      "first-page": "1267",
      "journal-title": "Mol Biol Rep",
      "key": "2385_CR180",
      "unstructured": "Vicente J, González-Andrade F, Soriano A, Fanlo A, Martínez-Jarreta B, Sinués B (2014) Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study. Mol Biol Rep 41:1267–1272. https://doi.org/10.1007/s11033-013-2971-y",
      "volume": "41",
      "year": "2014"
    },
    {
      "author": "N von Ahsen",
      "first-page": "310",
      "journal-title": "Int J Mol Epidemiol Genet",
      "key": "2385_CR181",
      "unstructured": "von Ahsen N, Tzvetkov M, Karunajeewa HA, Gomorrai S, Ura A, Brockmöller J, Davis TM, Mueller I, Ilett KF, Oellerich M (2010) CYP2D6 and CYP2C19 in Papua New Guinea: high frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess. Int J Mol Epidemiol Genet 1:310–319",
      "volume": "1",
      "year": "2010"
    },
    {
      "DOI": "10.1007/bf01799841",
      "author": "P Vreken",
      "doi-asserted-by": "publisher",
      "first-page": "645",
      "journal-title": "J Inherit Metab Dis",
      "key": "2385_CR182",
      "unstructured": "Vreken P, Van Kuilenburg AB, Meinsma R, Smit GP, Bakker HD, De Abreu RA, van Gennip AH (1996) A point mutation in an invariant splice donor site leads to exon skipping in two unrelated Dutch patients with dihydropyrimidine dehydrogenase deficiency. J Inherit Metab Dis 19:645–654. https://doi.org/10.1007/bf01799841",
      "volume": "19",
      "year": "1996"
    },
    {
      "DOI": "10.1016/j.jpeds.2019.09.024",
      "author": "M Wahlund",
      "doi-asserted-by": "publisher",
      "first-page": "150",
      "journal-title": "J Pediatr",
      "key": "2385_CR183",
      "unstructured": "Wahlund M, Nilsson A, Kahlin AZ, Broliden K, Myrberg IH, Appell ML, Berggren A (2020) The role of TPMT, ITPA, and NUDT15 variants during mercaptopurine treatment of Swedish pediatric patients with acute lymphoblastic leukemia. J Pediatr 216:150-157.e1. https://doi.org/10.1016/j.jpeds.2019.09.024",
      "volume": "216",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.alit.2020.11.004",
      "author": "T Watanabe",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "journal-title": "Allergol Int",
      "key": "2385_CR184",
      "unstructured": "Watanabe T, Go H, Saigusa Y, Takamura N, Watanabe Y, Yamane Y, Totsuka M, Ishikawa H, Nakamura K, Matsukura S, Kambara T, Takaki S, Yamaguchi Y, Aihara M (2021) Mortality and risk factors on admission in toxic epidermal necrolysis: a cohort study of 59 patients. Allergol Int 70:229–234. https://doi.org/10.1016/j.alit.2020.11.004",
      "volume": "70",
      "year": "2021"
    },
    {
      "DOI": "10.1097/01.gim.0000139506.11694.7c",
      "author": "MS Watson",
      "doi-asserted-by": "publisher",
      "first-page": "387",
      "journal-title": "Genet Med",
      "key": "2385_CR185",
      "unstructured": "Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW (2004) Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 6:387–391. https://doi.org/10.1097/01.gim.0000139506.11694.7c",
      "volume": "6",
      "year": "2004"
    },
    {
      "DOI": "10.1371/journal.pntd.0006440",
      "author": "J Watson",
      "doi-asserted-by": "publisher",
      "journal-title": "PLoS Negl Trop Dis",
      "key": "2385_CR186",
      "unstructured": "Watson J, Taylor WR, Bancone G, Chu CS, Jittamala P, White NJ (2018) Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria. PLoS Negl Trop Dis 12:e0006440. https://doi.org/10.1371/journal.pntd.0006440",
      "volume": "12",
      "year": "2018"
    },
    {
      "DOI": "10.1097/00008571-200107000-00005",
      "author": "A Wennerholm",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "journal-title": "Pharmacogenetics",
      "key": "2385_CR187",
      "unstructured": "Wennerholm A, Johansson I, Hidestrand M, Bertilsson L, Gustafsson LL, Ingelman-Sundberg M (2001) Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activity. Pharmacogenetics 11:417–427. https://doi.org/10.1097/00008571-200107000-00005",
      "volume": "11",
      "year": "2001"
    },
    {
      "DOI": "10.1038/s41525-021-00203-x",
      "author": "Q Xiao",
      "doi-asserted-by": "publisher",
      "first-page": "41",
      "journal-title": "NPJ Genom Med",
      "key": "2385_CR188",
      "unstructured": "Xiao Q, Lauschke VM (2021) The prevalence, genetic complexity and population-specific founder effects of human autosomal recessive disorders. NPJ Genom Med 6:41. https://doi.org/10.1038/s41525-021-00203-x",
      "volume": "6",
      "year": "2021"
    },
    {
      "DOI": "10.1038/ng.3060",
      "author": "SK Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1017",
      "journal-title": "Nat Genet",
      "key": "2385_CR189",
      "unstructured": "Yang SK, Hong M, Baek J, Choi H, Zhao W, Jung Y, Haritunians T, Ye BD, Kim KJ, Park SH, Park SK, Yang DH, Dubinsky M, Lee I, McGovern DP, Liu J, Song K (2014) A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia. Nat Genet 46:1017–1020. https://doi.org/10.1038/ng.3060",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1001/jamainternmed.2015.3536",
      "author": "CY Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1550",
      "journal-title": "JAMA Intern Med",
      "key": "2385_CR190",
      "unstructured": "Yang CY, Chen CH, Deng ST, Huang CS, Lin YJ, Chen YJ, Wu CY, Hung SI, Chung WH (2015a) Allopurinol use and risk of fatal hypersensitivity reactions: a nationwide population-based study in Taiwan. JAMA Intern Med 175:1550–1557. https://doi.org/10.1001/jamainternmed.2015.3536",
      "volume": "175",
      "year": "2015"
    },
    {
      "DOI": "10.1200/jco.2014.59.4671",
      "author": "JJ Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1235",
      "journal-title": "J Clin Oncol",
      "key": "2385_CR191",
      "unstructured": "Yang JJ, Landier W, Yang W, Liu C, Hageman L, Cheng C, Pei D, Chen Y, Crews KR, Kornegay N, Wong FL, Evans WE, Pui CH, Bhatia S, Relling MV (2015b) Inherited NUDT15 variant is a genetic determinant of mercaptopurine intolerance in children with acute lymphoblastic leukemia. J Clin Oncol 33:1235–1242. https://doi.org/10.1200/jco.2014.59.4671",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1038/clpt.2008.141",
      "author": "SU Yasuda",
      "doi-asserted-by": "publisher",
      "first-page": "417",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR192",
      "unstructured": "Yasuda SU, Zhang L, Huang SM (2008) The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies. Clin Pharmacol Ther 84:417–423. https://doi.org/10.1038/clpt.2008.141",
      "volume": "84",
      "year": "2008"
    },
    {
      "DOI": "10.1111/j.1365-2710.2011.01298.x",
      "author": "SJ Yin",
      "doi-asserted-by": "publisher",
      "first-page": "364",
      "journal-title": "J Clin Pharm Ther",
      "key": "2385_CR193",
      "unstructured": "Yin SJ, Ni YB, Wang SM, Wang X, Lou YQ, Zhang GL (2012) Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations. J Clin Pharm Ther 37:364–369. https://doi.org/10.1111/j.1365-2710.2011.01298.x",
      "volume": "37",
      "year": "2012"
    },
    {
      "DOI": "10.1016/j.pharmthera.2012.12.007",
      "author": "UM Zanger",
      "doi-asserted-by": "publisher",
      "first-page": "103",
      "journal-title": "Pharmacol Ther",
      "key": "2385_CR194",
      "unstructured": "Zanger UM, Schwab M (2013) Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther 138:103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007",
      "volume": "138",
      "year": "2013"
    },
    {
      "DOI": "10.3390/ijms21186627",
      "author": "Z Zazuli",
      "doi-asserted-by": "publisher",
      "journal-title": "Int J Mol Sci",
      "key": "2385_CR195",
      "unstructured": "Zazuli Z, Duin N, Jansen K, Vijverberg SJH, Maitland-van der Zee AH, Masereeuw R (2020) The impact of genetic polymorphisms in organic cation transporters on renal drug disposition. Int J Mol Sci. https://doi.org/10.3390/ijms21186627",
      "year": "2020"
    },
    {
      "DOI": "10.3402/ljm.v10.27053",
      "author": "HB Zeglam",
      "doi-asserted-by": "publisher",
      "first-page": "27053",
      "journal-title": "Libyan J Med",
      "key": "2385_CR196",
      "unstructured": "Zeglam HB, Benhamer A, Aboud A, Rtemi H, Mattardi M, Saleh SS, Bashein A, Enattah N (2015) Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population. Libyan J Med 10:27053. https://doi.org/10.3402/ljm.v10.27053",
      "volume": "10",
      "year": "2015"
    },
    {
      "author": "JP Zhang",
      "first-page": "385",
      "journal-title": "Ai Zheng",
      "key": "2385_CR197",
      "unstructured": "Zhang JP, Guan YY, Wu JH, Jiang WQ, Huang M (2003) Genetic polymorphism of the thiopurine S-methyltransferase of healthy Han Chinese. Ai Zheng 22:385–388",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1002/mgg3.1540",
      "author": "Y Zheng",
      "doi-asserted-by": "publisher",
      "journal-title": "Mol Genet Genomic Med",
      "key": "2385_CR198",
      "unstructured": "Zheng Y, Wang J, Liang X, Huang H, Ma Y, Lin L, Wang C, Zhan X, Yang L, Zha G, Yang P, Zou X, Chen Z, Chen X, Chen W, Liu X, Lin M (2020) Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations. Mol Genet Genomic Med 8:e1540. https://doi.org/10.1002/mgg3.1540",
      "volume": "8",
      "year": "2020"
    },
    {
      "DOI": "10.1136/jmedgenet-2018-105429",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "617",
      "journal-title": "J Med Genet",
      "key": "2385_CR199",
      "unstructured": "Zhou Y, Lauschke VM (2018) Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews. J Med Genet 55:617–627. https://doi.org/10.1136/jmedgenet-2018-105429",
      "volume": "55",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.690",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR200",
      "unstructured": "Zhou Y, Ingelman-Sundberg M, Lauschke VM (2017) Worldwide distribution of cytochrome P450 alleles: a meta-analysis of population-scale sequencing projects. Clin Pharmacol Ther 102:688–700. https://doi.org/10.1002/cpt.690",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41416-020-01084-0",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1782",
      "journal-title": "Br J Cancer",
      "key": "2385_CR201",
      "unstructured": "Zhou Y, Dagli Hernandez C, Lauschke VM (2020) Population-scale predictions of DPD and TPMT phenotypes using a quantitative pharmacogene-specific ensemble classifier. Br J Cancer 123:1782–1789. https://doi.org/10.1038/s41416-020-01084-0",
      "volume": "123",
      "year": "2020"
    },
    {
      "DOI": "10.1126/sciadv.abi6856",
      "doi-asserted-by": "crossref",
      "key": "2385_CR202",
      "unstructured": "Zhou Y, Herras Arribas G, Turku A, Jürgenson T, Mkrtchian S, Krebs K, Wang Y, Svobodova B, Milani L, Schulte G, Korabecny J, Gastaldello S, Lauschke VM (2021a) Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine. Sci Adv"
    },
    {
      "DOI": "10.1002/cpt.1944",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "160",
      "journal-title": "Clin Pharmacol Ther",
      "key": "2385_CR203",
      "unstructured": "Zhou Y, Krebs K, Milani L, Lauschke VM (2021b) Global frequencies of clinically important HLA alleles and their implications for the cost-effectiveness of preemptive pharmacogenetic testing. Clin Pharmacol Ther 109:160–174. https://doi.org/10.1002/cpt.1944",
      "volume": "109",
      "year": "2021"
    }
  ],
  "reference-count": 203,
  "references-count": 203,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s00439-021-02385-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "141"
}